Asthma mixed form (mode), excluding more controls

ASTHMA_MIXED_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %J458 Registry filters: Hospital discharge: ICD-10 — J45.8 Cause of death: ICD-10 — J45.8 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: J10_ASTHMA, ALLERG_ASTHMA, VOCALCORDDYS, I9_HEARTFAIL, J10_HYPERSPNEUMONI, ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_MIXED_EXMORE
CONTROL_EXCLUDE	J10_ASTHMA\|ALLERG_ASTHMA\|VOCALCORDDYS\|I9_HEARTFAIL\|J10_HYPERSPNEUMONI\|ASTHMA_EXCL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%J458
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%J458
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma mixed form (mode), excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Asthma mixed form (mode)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	25457	12665	12623
Only index persons	21583	11039	10544
Unadjusted period prevalence (%)
Whole population	0.36	0.36	0.35
Only index persons	0.40	0.41	0.40
Median age at first event (years)
Whole population	40.31	48.39	31.78
Only index persons	36.53	46.30	26.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2410	1433	977
Unadjusted period prevalence (%)	0.48	0.51	0.45
Median age at first event (years)	54.00	49.55	60.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2467: Matched controls
24661

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I50.0

ICD-10 Finland

Congestive heart failure

69.2

318.9

174

R06.0

ICD-10 Finland

Dyspnoea

5.3

315.9

843

2184

R03AK06

ATC

salmeterol and fluticasone; inhalant

29.9

307.7

1083

629

J45

ICD-10 Finland

Asthma

18.0

307.7

569

404

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

6.6

307.7

647

1269

R03DC03

ATC

montelukast; oral

20.2

307.7

1098

943

R03BA08

ATC

ciclesonide; inhalant

12.2

307.7

432

422

R03BB04

ATC

tiotropium bromide; inhalant

53.6

307.7

692

178

J45.8

ICD-10 Finland

Mixed asthma

+∞

307.7

2467

H02AB06

ATC

prednisolone; systemic

10.8

307.7

1836

5223

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

161.7

307.7

166

R96

ICPC

Asthma

23.0

307.7

638

368

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

159.6

307.7

1975

605

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

25.0

307.7

296

134

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

56.1

307.7

266

R03AK07

ATC

formoterol and budesonide; inhalant

9.5

307.7

994

1635

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

76.1

307.7

561

J45.9

ICD-10 Finland

Asthma, unspecified

73.6

307.7

1448

467

R03AC12

ATC

salmeterol; inhalant

93.9

307.7

428

R03BA01

ATC

beclometasone; inhalant

16.9

307.7

921

839

J18.9

ICD-10 Finland

Pneumonia, unspecified

21.7

307.7

733

472

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

59.7

307.7

532

113

XG474

NOMESCO Finland

Exhalation nntrogen oxide

109.2

307.7

281

R03AK08

ATC

formoterol and beclometasone; inhalant

45.3

307.7

317

UGC12

NOMESCO Finland

Flexible bronchoscopy

29.6

307.7

319

123

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

140.4

307.7

241

J45.0

ICD-10 Finland

Predominantly allergic asthma

101.7

307.7

717

J46

ICD-10 Finland

Status asthmaticus

201.1

307.7

220

J45.1

ICD-10 Finland

Nonallergic asthma

146.0

307.7

473

I50.9

ICD-10 Finland

Heart failure, unspecified

26.5

307.7

314

135

R03AC13

ATC

formoterol; inhalant

34.1

307.7

342

116

R03AC03

ATC

terbutaline; inhalant

10.8

307.7

734

931

R03BA05

ATC

fluticasone; inhalant

15.8

307.7

1141

1270

R03DA04

ATC

theophylline; systemic, rectal

34.6

307.7

426

148

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

301.7

307.7

269

XG410

NOMESCO Finland

Flow-volume spirometry

42.4

307.7

217

R03BA02

ATC

budesonide; inhalant

14.6

307.7

1037

1165

R03AC02

ATC

salbutamol; inhalant

32.0

307.7

2274

6642

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

21.3

301.8

231

119

R03AK03

ATC

[U] fenoterol and ipratropium bromide

17.3

296.4

251

160

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

44.5

291.8

174

XG405

NOMESCO Finland

Education on PEF monitoring

96.6

263.2

137

R03BB01

ATC

ipratropium bromide; inhalant

19.2

262.3

210

119

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

9.7

252.6

314

366

R06.2

ICD-10 Finland

Wheezing

14.9

244.0

223

163

J01MA14

ATC

moxifloxacin; systemic

9.3

238.9

306

370

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

7.6

229.0

353

531

H02AB04

ATC

methylprednisolone; systemic

5.5

225.0

507

1109

R01AD08

ATC

fluticasone; nasal

4.0

218.3

882

3031

R03DC01

ATC

zafirlukast; oral

54.3

208.9

119

XQ800

NOMESCO Finland

Prick test

7.8

204.8

304

437

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

10.0

204.4

244

268

TDM10

NOMESCO Finland

Puncture of maxillary antrum

105.2

195.8

101

R03AK11

ATC

formoterol and fluticasone; inhalant

22.3

189.7

141

R06AE07

ATC

cetirizine; oral

3.3

184.8

1308

6280

R01AD01

ATC

beclometasone; nasal

4.5

183.7

542

1465

J01FA06

ATC

roxithromycin; oral

3.3

183.2

1141

5072

J33.0

ICD-10 Finland

Polyp of nasal cavity

59.0

182.0

102

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

368.2

173.6

173

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

354.3

167.3

167

J01AA02

ATC

doxycycline; systemic

4.0

166.0

2007

12928

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

76.0

163.6

SPAT1059

SPAT

Spirometry at the office

8.3

163.3

224

292

C03CA01

ATC

furosemide; systemic

3.5

160.6

728

2630

R95

ICPC

Chron obstructive pulmonary disease

31.3

160.4

105

Z01.8

ICD-10 Finland

Other specified special examinations

3.5

160.2

720

2587

R01AD09

ATC

mometasone; nasal

3.0

158.3

1213

5952

R02

ICPC

Shortness of breath/dyspnoea

4.9

158.2

391

912

TGC00

NOMESCO Finland

Bronchial lavation

50.6

152.3

H02AB07

ATC

prednisone; oral

4.5

151.3

426

1101

J34.2

ICD-10 Finland

Deviated nasal septum

38.2

148.9

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

381.6

145.5

145

R03BC03

ATC

nedocromil; inhalant

6.1

145.1

271

491

J31.0

ICD-10 Finland

Chronic rhinitis

7.7

141.6

206

287

RD211, ,

NOMESCO Finland

6.7

140.7

237

387

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

139.9

133

49300

ICD-8 Finland

Asthma, bronchiale

+∞

132.5

126

R03BC01

ATC

cromoglicic acid; inhalant

19.9

132.5

103

J35.0

ICD-10 Finland

Chronic tonsillitis

33.4

131.0

EMB10

NOMESCO Finland

Tonsillectomy

25.5

129.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

126.9

1329

7428

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.2

126.1

618

2304

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.8

122.6

302

697

R06AX27

ATC

desloratadine; oral

2.9

119.5

807

3588

J30.3

ICD-10 Finland

Other allergic rhinitis

11.3

119.0

127

118

R01AD58

ATC

fluticasone, combinations; nasal

3.0

117.2

650

2592

UDH02

NOMESCO Finland

Rhinopharyngoscopy

8.2

113.9

155

199

J01FA10

ATC

azithromycin; systemic

2.6

113.5

1496

9172

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.6

112.9

1219

6797

R01AD05

ATC

budesonide; nasal

5.3

111.7

242

500

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

24.7

111.4

WZC30

NOMESCO Finland

Teaching

3.4

109.2

476

1641

J96.1

ICD-10 Finland

Chronic respiratory failure

+∞

108.1

103

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

225.7

105.4

108

R01AD12

ATC

fluticasone furoate; nasal

2.7

104.5

804

3780

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

14.6

102.6

J01FA09

ATC

clarithromycin; systemic

2.6

102.1

807

3838

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

6.2

98.3

174

297

R01AD11

ATC

triamcinolone; nasal

4.4

98.1

270

677

Z71.8

ICD-10 Finland

Other specified counselling

2.5

96.8

880

4454

I50.1

ICD-10 Finland

Left ventricular failure

252.2

95.3

R06AX13

ATC

loratadine; oral

3.2

95.2

438

1552

S01GX01

ATC

cromoglicic acid; ophthalmic

2.8

95.1

590

2470

R06AX22

ATC

ebastine; oral

3.0

94.6

487

1841

RF410, ,

NOMESCO Finland

12.5

94.6

SPAT1058

SPAT

PEF monitoring instruction

4.4

94.6

253

620

R04.2

ICD-10 Finland

Haemoptysis

10.4

94.2

106

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

92.7

364

1168

R01AC01

ATC

cromoglicic acid; nasal

6.7

92.6

151

237

J47

ICD-10 Finland

Bronchiectasis

932.1

92.4

Z3231

NOMESCO Finland

Registered nurse

2.6

89.3

719

3416

J37.0

ICD-10 Finland

Chronic laryngitis

18.2

88.1

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

47.3

86.9

RF420, ,

NOMESCO Finland

11.1

85.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

16.4

84.9

SPAT1252

SPAT

Overall medication plan or its review

4.2

84.1

239

612

R06AE09

ATC

levocetirizine; oral

3.1

84.0

413

1514

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

13.3

83.8

Z00.0

ICD-10 Finland

General medical examination

2.7

83.6

582

2567

J36

ICD-10 Finland

Peritonsillar abscess

45.4

82.7

UDM02

NOMESCO Finland

Sinoscopy

22.7

82.0

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.5

81.7

689

3326

R05

ICD-10 Finland

Cough

2.7

81.0

530

2262

XG466

NOMESCO Finland

Sleep oxymetry

9.7

80.7

101

C01CA24

ATC

epinephrine; parenteral

4.6

80.2

203

475

R5140

NOMESCO Finland

Monitoring the use of the aid

3.5

79.1

295

912

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

32.5

78.9

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

792.7

78.8

N02AX02

ATC

tramadol; systemic, rectal

2.2

78.7

994

5696

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

74.3

G47.3

ICD-10 Finland

Sleep apnoea

2.7

73.7

494

2125

C07AB07

ATC

bisoprolol; oral

2.2

72.8

1072

6477

R01BA52

ATC

pseudoephedrine, combinations; oral

2.3

70.8

693

3542

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.3

70.0

723

3778

A01AB09

ATC

miconazole; local oral

3.5

69.5

255

778

A02BC03

ATC

lansoprazole; oral

2.3

68.7

683

3508

A02BC02

ATC

pantoprazole; systemic

2.1

68.3

1532

10756

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

686.6

68.3

R06AX26

ATC

fexofenadine; oral

3.9

68.1

213

583

A02BC05

ATC

esomeprazole; systemic

2.1

67.4

924

5393

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

123.5

67.2

J01FA15

ATC

telithromycin; oral

3.5

67.0

244

740

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

65.6

1006

6111

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.5

65.3

504

2308

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

64.9

252

796

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.4

64.6

571

2779

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

5.6

62.9

123

230

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

61.5

788

4450

J35.2

ICD-10 Finland

Hypertrophy of adenoids

612.7

61.0

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

16.1

60.7

R05

ICPC

Cough

2.3

60.3

566

2817

SPAT1057

SPAT

Peak expiratory flow measurement

8.1

59.4

101

J01DA01

ATC

[U] cefalexin

2.0

59.2

1439

10173

J01MA12

ATC

levofloxacin; systemic

2.6

58.9

383

1610

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

57.1

869

5201

N03AX12

ATC

[U] gabapentin; oral

2.6

56.6

382

1634

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

56.2

637

3411

DJD20

NOMESCO Finland

Plastic repair of septum of nose

122.9

56.0

J01CA04

ATC

amoxicillin; systemic

2.2

55.9

1943

15457

C03DA01

ATC

spironolactone; oral

3.2

55.5

238

797

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

13.6

55.4

M54.5

ICD-10 Finland

Low back pain

2.0

55.3

830

4932

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

7.9

54.5

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

54.4

EMB30

NOMESCO Finland

Adenotomy

9.6

54.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

190.8

54.2

XG460

NOMESCO Finland

Short time oxymetry

11.0

52.2

R50.9

ICD-10 Finland

Fever, unspecified

2.7

52.2

326

1339

A02BC01

ATC

omeprazole; systemic

2.1

52.2

622

3384

R05FB02

ATC

cough suppressants and expectorants; systemic

2.0

52.1

841

5105

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

8.8

51.3

R51.80

ICD-10 Finland

Headache

2.5

50.5

377

1685

J01FF01

ATC

clindamycin; systemic

2.1

50.5

579

3099

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

14.2

50.2

DHB20

NOMESCO Finland

Polypectomy of internal nose

110.4

50.0

J33.8

ICD-10 Finland

Other polyp of sinus

92.0

49.0

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

48.9

441

2140

SPAT1359

SPAT

Use of symptom diary

5.3

48.3

193

N03AX16

ATC

[U] pregabalin

2.2

48.3

486

2467

R03CC02

ATC

salbutamol; systemic

3.2

47.8

207

696

RF120, ,

NOMESCO Finland

8.6

46.9

E0000UV, ,

ATC

1.9

46.9

977

6403

SPAT1325

SPAT

Vaccination

1.9

46.5

832

5187

A07AA02

ATC

nystatin; oral

3.8

46.2

149

415

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

46.1

301

1261

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

46.1

172

528

J02AC01

ATC

fluconazole; systemic

1.9

45.2

890

5713

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

5.9

45.0

140

R06.5

ICD-10 Finland

Mouth breathing

3.1

44.6

199

681

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

44.3

243

931

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.9

44.3

134

357

N02BE01

ATC

paracetamol; systemic, rectal

2.1

44.2

2045

17099

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

43.9

R81

ICPC

Pneumonia

6.1

43.7

127

R05FA02

ATC

opium derivatives and expectorants; systemic

1.8

43.4

909

5929

J20

ICD-10 Finland

Acute bronchitis

2.9

43.1

222

823

J01DB01

ATC

cefalexin; oral

1.9

43.0

1866

15155

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

81.6

43.0

RF210, ,

NOMESCO Finland

4.7

42.9

101

222

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.5

42.5

107

248

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

41.9

406

2019

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

15.9

41.8

E66.01

ICD-10 Finland

Obesity due to excess calories

2.9

41.7

210

768

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

41.7

893

5849

GD1AD

NOMESCO Finland

Thorax CT examination

4.8

41.5

208

ZX120

NOMESCO Finland

Intravenous

2.8

41.4

217

811

SPAT1257

SPAT

Teaching of medicine inhalation technique

5.1

41.4

181

L20.0

ICD-10 Finland

Besnier prurigo

2.9

41.2

209

768

J32.4

ICD-10 Finland

Chronic pansinusitis

145.8

40.9

A02BA02

ATC

ranitidine; systemic

2.2

40.8

426

2181

R53

ICD-10 Finland

Malaise and fatigue

2.0

40.6

531

2955

R60.0

ICD-10 Finland

Localized oedema

2.5

40.5

276

1177

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

10.4

40.5

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.2

40.5

167

545

I42.0

ICD-10 Finland

Dilated cardiomyopathy

10.6

40.2

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

208.3

39.9

A01AB04

ATC

amphotericin B; local oral

3.9

39.9

122

327

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.6

39.8

215

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

39.7

R03BB02

ATC

oxitropium bromide; inhalant

53.2

39.6

R05CA10

ATC

expectorants - combinations

5.6

39.5

140

Z51.6

ICD-10 Finland

Desensitization to allergens

58.5

39.4

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.4

39.3

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

39.3

395

1991

N06AX21

ATC

duloxetine; oral

2.5

39.1

257

1077

C01AA05

ATC

digoxin; systemic

3.2

38.9

161

526

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

38.6

T78.4

ICD-10 Finland

Allergy, unspecified

3.7

38.2

123

342

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.7

37.9

199

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

104.2

37.8

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

135.4

37.8

SPAT1254

SPAT

Administration of medicine

2.2

37.7

353

1727

R28

ICPC

Limited function/disability (R)

12.0

37.7

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

37.0

315

1481

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

36.5

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

36.0

688

4314

HMAK, ,

NOMESCO Finland

2.3

35.8

312

1480

J01DA06

ATC

[U] cefuroxime

2.3

35.7

310

1468

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

35.5

J01MA02

ATC

ciprofloxacin; systemic

1.8

35.2

815

5403

R05CB01

ATC

acetylcysteine; inhalant, oral

8.8

34.9

N06AX16

ATC

venlafaxine; oral

2.2

34.7

310

1485

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

4.5

34.7

197

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

34.6

776

5091

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

34.6

388

2033

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

34.5

206

822

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.6

34.4

186

R1250

NOMESCO Finland

Evaluation of functional capability

4.8

34.2

163

SPAT1131

SPAT

Colonoscopy

3.9

34.2

102

269

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

8.1

34.1

SPAT1263

SPAT

Sampling

1.7

33.8

928

6432

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

33.5

561

3366

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

33.4

M79.6

ICD-10 Finland

Pain in limb

1.7

33.2

874

5983

C08DA01

ATC

verapamil; systemic

3.7

32.9

105

290

J96.0

ICD-10 Finland

Acute respiratory failure

+∞

32.4

B01AA03

ATC

warfarin; systemic

2.1

32.2

355

1845

H02AB09

ATC

hydrocortisone; systemic

5.2

32.1

129

R03BB07

ATC

umeclidinium bromide; inhalant

43.9

31.9

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

31.8

223

961

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

167.1

31.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

31.6

170

643

DHB50

NOMESCO Finland

Turbinoplasty

48.2

31.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

31.6

206

858

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

36.9

31.5

AN1

Coronary angiography

2.5

31.3

211

892

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

4.1

31.1

223

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

30.7

392

2144

N05CF01

ATC

zopiclone; oral

1.8

30.7

664

4286

R29

ICPC

Respiratory symptom/complaint other

2.9

30.6

145

512

I45.9

ICD-10 Finland

Conduction disorder, unspecified

10.8

30.4

N02AA05

ATC

oxycodone; systemic

2.1

30.4

342

1789

J04.0

ICD-10 Finland

Acute laryngitis

4.3

30.2

189

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

8.8

30.2

Angiography of the heart and coronary arteries

3.0

30.0

135

463

N06AA09

ATC

amitriptyline; systemic

2.5

30.0

207

885

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.4

29.9

222

981

N06AX11

ATC

mirtazapine; oral

1.7

29.8

692

4550

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

108.0

29.7

A46

ICD-10 Finland

Erysipelas

2.2

29.5

271

1310

E000002, ,

ATC

2.2

29.3

267

1286

R49.08

ICD-10 Finland

Other specified dysphonia

5.7

29.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.2

29.1

116

370

N05BA04

ATC

oxazepam; oral

1.8

29.0

559

3482

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.4

28.9

174

R42

ICD-10 Finland

Dizziness and giddiness

1.8

28.8

489

2933

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

4.1

28.6

201

Z00.8

ICD-10 Finland

Other general examinations

2.5

28.6

198

847

E66.9

ICD-10 Finland

Obesity, unspecified

3.9

28.6

228

M04AA01

ATC

allopurinol; systemic

2.3

28.5

239

1113

J01DA09

ATC

[U] cefadroxil

1.8

28.3

560

3511

J43.9

ICD-10 Finland

Emphysema, unspecified

55.7

28.2

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

+∞

28.2

J01FA01

ATC

erythromycin; systemic

2.0

28.1

321

1685

R03AC18

ATC

indacaterol; inhalant

64.7

28.0

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.8

825

5768

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

146.6

27.7

SPAT1310

SPAT

Counselling related to known health issue

1.7

27.6

713

4807

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

27.6

140

513

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

27.2

386

2182

S15

ICPC

Foreign body in skin

2.6

27.2

164

657

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

27.1

SPAT1360

SPAT

Extensive global examination

2.5

26.9

170

696

S01GX02

ATC

levocabastine; ophthalmic

2.7

26.8

144

544

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

28.1

26.7

I20.00

ICD-10 Finland

Unstable angina

4.4

26.3

153

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

26.2

501

3105

J01DA08

ATC

[U] cefaclor

2.1

26.1

272

1378

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

26.1

N06AB04

ATC

citalopram; systemic

1.8

25.8

409

2393

WQ000

NOMESCO Finland

Hyposensibilisation

73.4

25.8

M03BX02

ATC

tizanidine; oral

1.6

25.6

1274

10004

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

25.6

152

604

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

25.5

199

898

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.2

25.3

104

338

E000001, ,

ATC

1.8

25.2

431

2581

D07AC13

ATC

mometasone; topical

1.7

25.1

606

3997

R74

ICPC

Upper respiratory infection acute

1.7

25.0

661

4464

M79.7

ICD-10 Finland

Fibromyalgia

3.7

24.9

222

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

24.9

258

1305

SPAT1216

SPAT

Assessment of functional ability

1.9

24.6

336

1872

M05BA04

ATC

alendronic acid; oral

2.4

24.6

181

795

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

24.5

730

5074

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.4

24.5

169

721

S18

ICPC

Laceration/cut

1.6

24.4

926

6814

M48.0

ICD-10 Finland

Spinal stenosis

2.1

24.4

244

1216

M25.5

ICD-10 Finland

Pain in joint

1.7

24.3

636

4278

L28

ICPC

Limited function/disability (L)

1.9

24.3

345

1947

J35.1

ICD-10 Finland

Hypertrophy of tonsils

48.8

24.3

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.9

24.1

110

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

24.1

155

640

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.9

24.0

114

403

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

+∞

24.0

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

24.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

23.7

248

1257

R52.2

ICD-10 Finland

Other chronic pain

3.5

23.7

249

C01BD01

ATC

amiodarone; systemic

5.0

23.7

104

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

6.2

23.6

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

41.8

23.6

D07AC01

ATC

betamethasone; topical

1.6

23.6

731

5122

ZXA10

NOMESCO Finland

Bilateral

1.9

23.6

352

2018

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

23.5

1193

9341

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

23.5

187

850

SPAT1301

SPAT

No procedures

1.6

23.1

671

4623

H66.9

ICD-10 Finland

Otitis media, unspecified

2.5

23.1

149

616

R07.3

ICD-10 Finland

Other chest pain

2.2

23.1

203

962

N05BB01

ATC

hydroxyzine; systemic

2.5

23.0

146

599

132

Kela drug reimbursment

Sarcoidosis

+∞

22.9

D07AA02

ATC

hydrocortisone; topical

1.9

22.9

309

1714

Z50.5

ICD-10 Finland

Speech therapy

5.9

22.7

Z72.0

ICD-10 Finland

Tobacco use

4.9

22.7

104

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.9

22.7

180

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

232.0

22.6

R06AX11

ATC

astemizole; oral

3.4

22.6

242

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

22.6

324

1833

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

22.5

592

3976

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

22.2

180

825

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

22.1

504

3263

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

22.0

301

1675

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

21.9

EMB20

NOMESCO Finland

Adenotonsillectomy

80.8

21.7

K77

ICPC

Heart failure

7.8

21.7

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

7.0

21.6

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.0

21.6

159

RP210, ,

NOMESCO Finland

221.8

21.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

21.5

270

1461

E66.8

ICD-10 Finland

Other obesity

2.8

21.4

113

423

N05BA01

ATC

diazepam; systemic, rectal

2.0

21.4

259

1383

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

8.3

21.4

UJF32

NOMESCO Finland

Coloscopy

1.7

21.3

482

3109

49099

ICD-8 Finland

Bronchitis, unspecified

7.6

21.2

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

21.1

109

403

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

21.1

384

2331

N05CD07

ATC

temazepam; oral

2.0

21.1

237

1233

Z51.0

ICD-10 Finland

Radiotherapy session

4.7

21.0

103

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

60.5

20.9

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

20.9

N05AH04

ATC

quetiapine; oral

1.8

20.8

344

2031

M01AE02

ATC

naproxen; oral, rectal

1.5

20.6

1213

9698

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

4.9

20.6

-1, ,

NOMESCO Finland

1.6

20.6

737

5307

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

20.6

315

1816

J42

ICD-10 Finland

Unspecified chronic bronchitis

17.0

20.5

R49.01

ICD-10 Finland

Functional dysphonia

3.7

20.4

180

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.6

20.3

106

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

20.2

601

4146

J30.0

ICD-10 Finland

Vasomotor rhinitis

4.9

20.1

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

20.1

245

A41.9

ICD-10 Finland

Sepsis, unspecified

3.5

20.1

196

J01DC02

ATC

cefuroxime; systemic

2.7

20.0

110

421

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.9

20.0

276

1540

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

19.9

112

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

19.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

19.8

706

5073

L03

ICPC

Low back symptom/complaint

1.6

19.7

554

3768

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

19.6

258

1416

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

19.6

167

781

J01.1

ICD-10 Finland

Acute frontal sinusitis

7.8

19.5

A03

ICPC

Fever

1.8

19.5

335

1997

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

19.5

225

1181

I47.2

ICD-10 Finland

Ventricular tachycardia

4.9

19.5

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

19.3

180

872

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

5.1

19.3

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

19.3

198

996

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.2

19.2

242

A03FA02

ATC

cisapride; oral, rectal

2.2

19.2

163

761

N06AB03

ATC

fluoxetine; oral

1.9

19.1

248

1354

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

19.1

830

6210

R83

ICPC

Respiratory infection other

1.6

19.1

545

3716

XA402

NOMESCO Finland

ENMG

3.8

19.1

160

A06AD11

ATC

lactulose; oral

1.8

19.0

285

1631

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

19.0

230

1227

GX2C5

NOMESCO Finland

Short-lasting oximetry

34.6

18.9

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.0

18.9

276

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.0

18.9

276

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

18.8

593

4135

A12BA01

ATC

potassium chloride; oral

3.0

18.8

287

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

18.8

300

1750

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

18.8

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

18.8

DPA30

NOMESCO Finland

Sphenotomy

+∞

18.8

V01AA05

ATC

tree pollen; parenteral

8.1

18.8

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

18.6

160

750

Z08

ICPC

Social welfare problem

5.4

18.5

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.0

18.5

136

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

18.5

422

2720

WW200

NOMESCO Finland

Immunization

3.8

18.4

150

R52.9

ICD-10 Finland

Pain, unspecified

2.1

18.4

192

971

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

18.4

341

GX1K5

NOMESCO Finland

Diffusion capacity

30.3

18.3

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

18.3

297

SPAT1260

SPAT

Consultation of another employee

1.7

18.3

349

2143

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

18.3

310

1841

M01AH02

ATC

rofecoxib; oral

1.9

18.1

239

1312

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

18.0

339

2073

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

18.0

965

7508

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.9

18.0

300

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

4.7

18.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

18.0

108

432

M10.9

ICD-10 Finland

Gout, unspecified

2.5

18.0

113

462

SPAT1097

SPAT

Recording of ECG

1.8

17.8

280

1624

D07BC01

ATC

betamethasone and antiseptics; topical

1.9

17.8

235

1290

SPAT1240

SPAT

Therapeutic discussion

1.9

17.8

231

1262

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

22.9

17.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

17.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

+∞

17.7

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

17.7

104

412

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

181.2

17.5

R06AX12

ATC

terfenadine; oral

2.6

17.5

100

390

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

29.0

17.4

XA420

NOMESCO Finland

Extensive sleep examination

7.1

17.4

WX722

NOMESCO Finland

PEEP

3.2

17.3

226

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.6

17.2

102

406

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

17.1

593

4211

R01AC07

ATC

nedocromil; nasal

12.6

17.1

R2110

NOMESCO Finland

Giving the first information

2.3

17.0

137

626

XG405, ,

SPAT

7.6

17.0

4224

FHL

Endonasal anthrostomy

7.6

17.0

207

Kela drug reimbursment

Chronic arrhythmias

1.9

16.9

244

1378

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

16.9

411

2688

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

16.9

374

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

22.0

16.8

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

16.7

348

Kela drug reimbursment

Roflumilast

+∞

16.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

16.6

396

2576

I20.09

ICD-10 Finland

Unstable angina

2.5

16.5

100

402

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.4

16.4

118

513

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.4

16.4

B01AC04

ATC

clopidogrel; oral

1.8

16.4

274

1618

PLAK1, ,

NOMESCO Finland

4.4

16.4

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.7

16.3

PLAK0, ,

NOMESCO Finland

5.2

16.3

R07

ICPC

Sneezing/nasal congestion

2.2

16.2

135

625

N03AX09

ATC

lamotrigine; oral

2.7

16.2

341

J33.9

ICD-10 Finland

Nasal polyp, unspecified

12.9

16.1

RF421, ,

NOMESCO Finland

7.1

16.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

15.9

458

3114

SPAT1255

SPAT

Intravenous administration of medicine

2.3

15.9

121

540

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

15.8

299

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

15.8

357

2290

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

33.6

15.7

WW200, ,

SPAT

1.6

15.7

468

3209

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

15.7

125

569

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

15.6

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

+∞

15.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

15.6

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

15.6

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

15.6

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

+∞

15.6

C08DB01

ATC

diltiazem; oral

2.4

15.6

109

468

A02BX02

ATC

sucralfate; oral

2.7

15.6

330

E000003, ,

ATC

2.6

15.6

377

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

26.4

15.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

15.5

218

1220

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

15.5

415

2773

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

160.9

15.5

N02BF02

ATC

pregabalin; oral

2.4

15.5

103

433

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

15.4

118

528

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

15.4

238

1373

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.2

15.3

190

I50

ICD-10 Finland

Heart failure

5.2

15.3

GD1AA, ,

SPAT

1.9

15.3

212

1181

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.7

15.3

GX1E5, ,

SPAT

6.7

15.3

XQ848

NOMESCO Finland

Dermatological photography

2.9

15.2

249

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.9

15.2

N06AB10

ATC

escitalopram; oral

1.6

15.2

400

2661

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.4

15.2

161

RF220, ,

NOMESCO Finland

4.7

15.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

15.1

228

1305

KHV, ,

NOMESCO Finland

5.7

15.1

A02BA04

ATC

nizatidine; systemic

2.1

15.1

147

725

C10AA01

ATC

simvastatin; oral

1.4

15.1

773

5916

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

15.0

188

1013

C01DA14

ATC

isosorbide mononitrate; oral

1.7

15.0

269

1619

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

15.0

441

3012

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.9

14.9

252

D11AH01

ATC

tacrolimus; topical

5.8

14.9

RD210, ,

NOMESCO Finland

4.1

14.9

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

14.9

137

661

R03BA07

ATC

mometasone; inhalant

6.8

14.9

C08CA13

ATC

lercanidipine; oral

1.7

14.8

273

1656

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

14.8

320

2026

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

14.8

184

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

57.0

14.8

M79.1

ICD-10 Finland

Myalgia

1.7

14.7

274

1666

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

14.7

191

1042

N07BA03

ATC

varenicline; oral

2.7

14.7

305

R21

ICPC

Throat symptom/complaint

1.6

14.7

423

2874

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

14.6

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

14.6

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.1

14.5

137

667

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.6

14.5

348

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

150.8

14.5

J92.9

ICD-10 Finland

Pleural plaque without asbestos

150.8

14.5

ZXC60

NOMESCO Finland

Application of heat

6.6

14.5

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

14.5

818

6363

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

36.2

14.4

WX308

NOMESCO Finland

Sacral anesthesy

15.5

14.4

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

14.4

203

M05BA07

ATC

risedronic acid; oral

2.9

14.4

230

R4110, ,

SPAT

1.9

14.3

175

935

SPAT1153

SPAT

Removal of sutures

1.5

14.3

607

4471

N03AE01

ATC

clonazepam; systemic

2.4

14.3

101

436

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.0

14.3

S01GX08

ATC

ketotifen; ophthalmic

2.4

14.3

393

M01AH05

ATC

etoricoxib; oral

1.4

14.3

1215

10132

R03AC19

ATC

olodaterol

27.3

14.3

G44.2

ICD-10 Finland

Tension-type headache

1.7

14.2

249

1488

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.5

14.2

382

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

14.2

206

1165

N06AA12

ATC

doxepin; systemic

2.4

14.1

420

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

14.0

134

656

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.4

13.9

410

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

13.9

264

1613

S80.0

ICD-10 Finland

Contusion of knee

2.0

13.9

144

726

C07AB05

ATC

betaxolol; oral

3.0

13.9

207

X58

ICD-10 Finland

Exposure to other specified factors

1.7

13.9

264

1614

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

13.9

822

6436

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

13.8

344

2256

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.7

13.8

269

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

23.9

13.8

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

4.7

13.8

C08CA01

ATC

amlodipine; oral

1.4

13.7

681

5162

C09CA01

ATC

losartan; oral

1.5

13.7

464

3261

SPAT1098

SPAT

Exercise ECG

3.3

13.7

162

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

13.6

824

6469

J94.8

ICD-10 Finland

Other specified pleural conditions

75.5

13.6

I45.8

ICD-10 Finland

Other specified conduction disorders

12.1

13.6

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

13.5

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

13.5

R03DX07

ATC

roflumilast; oral

+∞

13.5

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.0

13.5

205

J15.8

ICD-10 Finland

Other bacterial pneumonia

34.2

13.5

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.0

13.5

200

J30.19

ICD-10 Finland

Pollen allergy UNS

2.6

13.5

313

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

140.7

13.5

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

140.7

13.5

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

13.4

141

715

R01AX03

ATC

ipratropium bromide; nasal

3.6

13.4

125

B37.08

ICD-10 Finland

Other candidal stomatitis

6.3

13.3

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.3

13.3

150

K05

ICPC

Irregular heartbeat other

2.6

13.2

281

H57.1

ICD-10 Finland

Ocular pain

2.6

13.1

305

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

13.1

213

1245

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.9

13.1

214

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

13.1

138

700

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

13.1

182

1015

M54.1

ICD-10 Finland

Radiculopathy

2.6

13.1

306

G04CA02

ATC

tamsulosin; oral

1.5

13.0

402

2769

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.8

13.0

104

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

13.0

171

938

R03AC04

ATC

fenoterol; inhalant

28.5

13.0

S06.0

ICD-10 Finland

Concussion

1.8

12.9

203

1176

N02AA01

ATC

morphine; systemic, rectal

4.0

12.9

UDC00

NOMESCO Finland

Ear microscopy

2.1

12.9

128

636

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

12.9

536

3924

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.4

12.9

ZX100

NOMESCO Finland

Oral

4.4

12.9

280

Kela drug reimbursment

Clopidogrel

4.5

12.8

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

12.8

206

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

12.8

401

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.8

12.7

R01AD59

ATC

mometasone, combinations; nasal

2.5

12.7

322

E66.0

ICD-10 Finland

Obesity due to excess calories

5.1

12.7

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

12.7

428

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

12.6

323

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

12.6

245

1507

V01AA02

ATC

grass pollen; parenteral

32.2

12.6

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

12.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

12.5

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

+∞

12.5

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

12.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

12.5

472

3388

N04BC05

ATC

pramipexole; oral

2.0

12.5

139

720

J38.2

ICD-10 Finland

Nodules of vocal cords

130.6

12.4

J32.1

ICD-10 Finland

Chronic frontal sinusitis

130.6

12.4

R11

ICD-10 Finland

Nausea and vomiting

1.9

12.4

156

843

Y0499

ICD-8 Finland

Investigation of respiratory system

4.7

12.3

E000006, ,

ATC

2.0

12.3

128

648

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.5

12.2

304

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

9.7

12.2

J01.4

ICD-10 Finland

Acute pansinusitis

37.7

12.2

GX1D5

NOMESCO Finland

Flow volume spirometry

37.7

12.2

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.7

12.2

250

1560

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.7

12.2

246

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.9

12.1

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

4.1

12.1

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.8

12.1

213

XG430

NOMESCO Finland

Spiroegometry

26.8

12.0

S97

ICPC

Chronic ulcer skin

2.3

12.0

425

M01AH01

ATC

celecoxib; oral

1.6

12.0

317

2104

M02AA07

ATC

piroxicam; topical

1.4

12.0

661

5086

J05AB01

ATC

aciclovir; systemic

1.5

12.0

409

2874

WZC30, ,

SPAT

2.1

11.9

111

538

N02BF01

ATC

gabapentin; oral

1.9

11.9

140

739

S22.3

ICD-10 Finland

Fracture of rib

2.0

11.9

125

635

J01EA01

ATC

trimethoprim; systemic

1.4

11.8

528

3910

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

11.8

409

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

11.8

130

672

H01

ICPC

Ear pain/earache

1.7

11.7

221

1347

ZX114

NOMESCO Finland

Intramuscular

4.0

11.7

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

11.7

307

2034

K07

ICPC

Swollen ankles/oedema

2.4

11.7

317

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

11.7

437

C09CA03

ATC

valsartan; oral

1.9

11.7

160

889

L27.2

ICD-10 Finland

Dermatitis due to ingested food

4.8

11.6

P29

ICPC

Psychological sympt/compl other

1.9

11.6

145

781

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

11.6

392

2747

H92.0

ICD-10 Finland

Otalgia

2.0

11.5

120

607

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.1

11.5

R03DA05

ATC

aminophylline; systemic, rectal

8.6

11.5

L50.0

ICD-10 Finland

Allergic urticaria

2.8

11.5

202

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

11.5

142

763

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

11.5

395

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

11.5

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

11.5

1503

13214

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

120.5

11.4

S01ED02

ATC

betaxolol; ophthalmic

4.8

11.4

N06AX12

ATC

bupropion; oral

2.0

11.4

126

651

A10BA02

ATC

metformin; oral

1.4

11.4

495

3643

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.2

11.4

144

R03

ICPC

Wheezing

5.4

11.3

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

11.3

186

1091

R39.1

ICD-10 Finland

Other difficulties with micturition

2.7

11.3

232

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

11.3

172

986

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

11.8

11.3

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

11.3

469

RJ190, ,

NOMESCO Finland

35.2

11.3

GDC00

NOMESCO Finland

Lobectomy of lung

35.2

11.3

R06

ICD-10 Finland

Abnormalities of breathing

5.1

11.3

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

10.6

11.3

L04AX01

ATC

azathioprine; systemic

2.5

11.2

286

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

11.2

103

497

J05AH02

ATC

oseltamivir; oral

9.6

11.2

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

11.2

129

676

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.3

11.2

348

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.9

11.2

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.0

11.2

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.7

11.2

222

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

11.2

210

1279

N02AC04

ATC

dextropropoxyphene; oral

2.4

11.2

305

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.4

11.2

305

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

11.2

287

H10.4

ICD-10 Finland

Chronic conjunctivitis

5.6

11.2

ZX112

NOMESCO Finland

Subcutaneous

3.2

11.1

136

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.9

11.0

142

773

P76

ICPC

Depressive disorder

2.0

11.0

123

638

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.0

11.0

R09

ICPC

Sinus symptom/complaint

1.9

11.0

139

752

A10BJ06

ATC

semaglutide; parenteral

2.3

11.0

351

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.8

11.0

T91

ICPC

Vitamin/nutritional deficiency

5.8

11.0

N39.3

ICD-10 Finland

Stress incontinence

1.9

10.9

139

754

D07AB08

ATC

desonide; topical

1.7

10.9

200

1210

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.8

10.9

SPAT1229

SPAT

Assessment of need for aid

1.9

10.9

132

704

J96.9

ICD-10 Finland

Respiratory failure, unspecified

43.5

10.9

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

10.9

397

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.6

10.9

237

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

10.9

232

1462

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

10.8

690

5424

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.3

10.8

118

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.2

10.8

SPAT1081

SPAT

Cardiorespiratory global assessment

2.1

10.8

465

4222

FHL

Endonasal etmoidectomy

10.6

10.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

10.7

268

1754

ZX140

NOMESCO Finland

Intra articular

4.9

10.7

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.4

10.7

299

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

10.7

493

3665

J38.3

ICD-10 Finland

Other diseases of vocal cords

21.5

10.7

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.1

10.7

P01

ICPC

Feeling anxious/nervous/tense

1.6

10.7

248

1596

C09CA06

ATC

candesartan; oral

1.5

10.7

413

2971

K59.0

ICD-10 Finland

Constipation

2.1

10.6

102

501

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

60.2

10.6

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.8

10.6

183

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

10.6

462

H65.2

ICD-10 Finland

Chronic serous otitis media

4.3

10.5

R39

ICPC

Respiratory, Physical function test

8.5

10.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

10.5

224

B02AA02

ATC

tranexamic acid; systemic

1.6

10.5

270

1781

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

110.4

10.4

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

110.4

10.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

110.4

10.4

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

10.4

213

1327

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

10.4

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

+∞

10.4

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

10.4

100

492

A28

ICPC

Limited function/disability NOS

1.6

10.4

276

1834

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

10.3

187

1128

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

10.3

323

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

10.3

342

M01AC06

ATC

meloxicam; systemic, rectal

1.4

10.3

667

5249

EBA00

NOMESCO Finland

Extraction of tooth

1.4

10.3

712

5664

N06AX03

ATC

mianserin; oral

2.2

10.2

388

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

10.2

299

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

10.2

467

3462

RF430, ,

NOMESCO Finland

9.6

10.2

R05CB02

ATC

bromhexine; systemic

3.7

10.2

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.8

10.2

181

A10BJ02

ATC

liraglutide; parenteral

2.9

10.2

170

L01

ICPC

Neck symptom/complaint

1.6

10.2

286

1922

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.6

10.2

227

R04

ICPC

Breathing problem other

2.4

10.2

281

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

10.2

354

2492

205

Kela drug reimbursment

Chronic hypertension

1.4

10.2

500

3757

E000007, ,

ATC

2.0

10.1

105

531

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

10.1

270

R13

ICD-10 Finland

Dysphagia

2.0

10.1

108

552

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

10.1

101

504

UDQ02

NOMESCO Finland

Direct laryngoscopy

7.9

10.1

4226

FHL

Posterior radical surgery and possible etmoidectomy

7.9

10.1

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.9

10.1

155

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.8

10.1

177

R55

ICD-10 Finland

Syncope and collapse

1.7

10.0

191

1168

A02BC04

ATC

rabeprazole; oral

1.8

10.0

148

842

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

9.2

10.0

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.2

10.0

119

GX1C5, ,

SPAT

14.6

10.0

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.1

10.0

486

XF640, ,

NOMESCO Finland

2.8

10.0

167

J98.1

ICD-10 Finland

Pulmonary collapse

40.2

10.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

9.9

135

K30

ICD-10 Finland

Functional dyspepsia

1.7

9.9

199

1234

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

9.9

122

655

M02AA10

ATC

ketoprofen; topical

1.5

9.9

286

1935

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

9.9

481

Z01.7

ICD-10 Finland

Laboratory examination

1.6

9.9

272

1821

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.4

9.9

261

ZX108

NOMESCO Finland

Inhalation

16.8

9.9

M54.3

ICD-10 Finland

Sciatica

2.0

9.8

107

551

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

26.1

9.8

AN2

Balloon angioplasty, including several vessels

2.7

9.8

191

D02AE01

ATC

carbamide; topical

1.9

9.8

119

636

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.9

9.8

Z3226

NOMESCO Finland

Physiotherapist

1.5

9.8

292

1991

G43.3

ICD-10 Finland

Complicated migraine

3.4

9.7

101

R06.4

ICD-10 Finland

Hyperventilation

3.7

9.7

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

55.2

9.6

R06AX18

ATC

acrivastine; oral

2.7

9.6

187

C07AA05

ATC

propranolol; systemic

1.5

9.6

370

2654

A01

ICPC

Pain general/multiple sites

1.8

9.6

151

875

UJC12

NOMESCO Finland

Flexible oesophagoscopy

7.8

9.6

J32

ICD-10 Finland

Chronic sinusitis

11.4

9.6

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

9.5

133

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

9.5

183

1123

ZY010

NOMESCO Finland

Hospital outpatient

2.1

9.5

448

N05BA12

ATC

alprazolam; oral

1.7

9.5

175

1062

N05CF02

ATC

zolpidem; oral

1.5

9.4

296

2038

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

100.4

9.4

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

100.4

9.4

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

7.6

9.4

48609

ICD-8 Finland

Pneumonia, unspecified

3.9

9.4

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

30.1

9.4

RF313, ,

NOMESCO Finland

17.6

9.4

4239

FHL

Other measure in this category

17.6

9.4

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.6

9.4

213

J93.9

ICD-10 Finland

Pneumothorax, unspecified

+∞

9.4

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

9.4

3028

Kela drug reimbursment

Mepolizumab

+∞

9.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

9.4

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

9.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

9.4

128

711

R5110, ,

SPAT

1.9

9.4

113

603

M01AX17

ATC

nimesulide; oral

1.4

9.4

411

3023

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.4

9.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

9.3

256

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

9.3

126

698

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

9.3

1069

9113

S01

ICPC

Pain/tenderness of skin

2.1

9.3

384

R01AC02

ATC

levocabastine; nasal

2.7

9.3

185

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.7

9.3

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.5

9.3

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

9.2

507

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

9.2

466

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

9.2

189

1179

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

9.2

501

RF310, ,

NOMESCO Finland

13.7

9.2

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

9.2

373

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

9.1

113

608

SPAT1251

SPAT

Organisation of medication

2.3

9.1

277

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.1

428

3185

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

9.1

113

609

S16

ICPC

Bruise/contusion

2.4

9.1

253

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

9.1

105

553

R01BA01

ATC

phenylpropanolamine; oral

2.0

9.0

463

N03AG01

ATC

valproic acid; systemic, rectal

2.0

9.0

484

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.0

282

1942

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

9.0

212

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

9.0

337

S76

ICPC

Skin infection other

2.0

8.9

444

Z51.5

ICD-10 Finland

Palliative care

1.9

8.9

115

627

R75

ICPC

Sinusitis acute/chronic

2.2

8.9

344

315

Kela drug reimbursment

Clopidogrel

4.2

8.9

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

8.9

312

R03DB04

ATC

theophylline and adrenergics; systemic

24.1

8.9

R78

ICPC

Acute bronchitis/bronchiolitis

3.2

8.9

107

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

8.9

414

3076

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

8.9

345

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.1

8.8

118

P06

ICPC

Sleep disturbance

1.6

8.8

193

1224

D07AD01

ATC

clobetasol; topical

1.5

8.8

295

2059

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

8.8

116

638

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

8.8

103

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

8.8

178

1108

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.9

8.7

140

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

8.7

156

939

R07.0

ICD-10 Finland

Pain in throat

1.8

8.7

119

662

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.9

8.7

J38.4

ICD-10 Finland

Oedema of larynx

50.1

8.7

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

50.1

8.7

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

50.1

8.7

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

50.1

8.7

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.5

8.6

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

3.4

8.6

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

3.0

8.6

125

R06AE08, ,

ATC

4.4

8.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

8.6

230

1530

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

16.3

8.5

XKD00

NOMESCO Finland

Uroflowmetry

1.5

8.5

261

1787

Z01.2

ICD-10 Finland

Dental examination

1.3

8.5

910

7656

A01AB10

ATC

natamycin; local oral

2.3

8.5

261

Z50.1

ICD-10 Finland

Other physical therapy

2.0

8.5

453

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.4

8.5

L04AX03

ATC

methotrexate; systemic

1.7

8.5

156

946

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

8.5

293

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.9

8.4

132

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

90.3

8.4

R03BB06

ATC

glycopyrronium bromide; inhalant

90.3

8.4

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

90.3

8.4

NOMESCO Finland

Other rehabilitation services

90.3

8.4

SPAT1267

SPAT

Desensitisation

90.3

8.4

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

8.4

126

721

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.2

8.4

340

M35.7

ICD-10 Finland

Hypermobility syndrome

3.5

8.4

UJD02

NOMESCO Finland

Gastroscopy

2.1

8.4

387

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

8.4

421

R03DX10

ATC

benralizumab; systemic

+∞

8.3

51899

ICD-8 Finland

Bronchiectasis

+∞

8.3

J93.8

ICD-10 Finland

Other pneumothorax

+∞

8.3

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

8.3

TGA30

NOMESCO Finland

Thoracocentesis

+∞

8.3

R03DX09

ATC

mepolizumab; parenteral

+∞

8.3

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

J43.8

ICD-10 Finland

Other emphysema

+∞

8.3

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

8.3

R05DB05

ATC

pentoxyverine; oral, rectal

2.3

8.3

276

A02BA03

ATC

famotidine; systemic

2.3

8.3

276

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

8.3

251

A11CC03

ATC

alfacalcidol; systemic

3.0

8.3

117

RJ411, ,

NOMESCO Finland

8.5

8.3

F03

ICPC

Eye discharge

1.8

8.3

121

687

J41.0

ICD-10 Finland

Simple chronic bronchitis

10.8

8.3

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

8.3

409

A10BX04

ATC

[U] exenatide

4.1

8.3

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

8.2

104

564

M54.2

ICD-10 Finland

Cervicalgia

1.7

8.2

138

816

R10.0

ICD-10 Finland

Acute abdomen

2.4

8.2

240

R05DA01

ATC

ethylmorphine; oral

1.7

8.2

133

779

S20.2

ICD-10 Finland

Contusion of thorax

2.0

8.2

459

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

8.2

146

878

K07.60

ICD-10 Finland

Snapping jaw

2.0

8.2

473

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

8.2

215

1424

GEA00

NOMESCO Finland

Mediastinoscopy

33.4

8.1

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

33.4

8.1

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

8.1

406

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

8.1

159

982

RJ410, ,

NOMESCO Finland

11.7

8.1

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

8.0

108

598

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

8.0

421

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

6.3

8.0

C09AA02

ATC

enalapril; systemic

1.4

8.0

326

2362

R25.2

ICD-10 Finland

Cramp and spasm

2.7

8.0

153

D02AX

ATC

Other emollients and protectives

2.3

8.0

243

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

8.0

194

1262

L16

ICPC

Ankle symptom/complaint

1.6

8.0

208

1375

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

7.9

203

1336

SPAT1236

SPAT

Informing family of child’s disability

2.6

7.9

171

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

7.9

132

780

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

7.9

335

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

7.9

122

705

R5599

NOMESCO Finland

Other rehabilitation service

2.4

7.9

232

48509

ICD-8 Finland

Bronchopneumonia, unspecified

4.0

7.9

250, ,

Kela drug reimbursment

13.1

7.9

N06AX26

ATC

vortioxetine; oral

1.7

7.9

127

743

C08CA05

ATC

nifedipine; systemic

1.8

7.8

111

625

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.8

218

1463

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

7.8

343

RF110, ,

NOMESCO Finland

8.5

7.8

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

7.8

330

R01AD

ATC

Corticosteroids

4.1

7.8

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.9

7.8

127

T82

ICPC

Obesity

2.1

7.8

317

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

9.4

7.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

7.8

119

686

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

7.8

440

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

7.7

242

1664

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.7

7.7

156

J12.8

ICD-10 Finland

Other viral pneumonia

45.1

7.7

D72.1

ICD-10 Finland

Eosinophilia

45.1

7.7

4719X

ICD-9 Finland

Nasal polyps, Unspecified nasal polyp

45.1

7.7

WX723

NOMESCO Finland

CPAP therapy

2.2

7.7

292

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.9

7.7

L86

ICPC

Back syndrome with radiating pain

1.8

7.7

102

563

R5120

NOMESCO Finland

Preparation of an aid

2.3

7.7

235

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

7.7

160

Kela drug reimbursment

exenatide

3.0

7.7

112

WYA00, ,

SPAT

3.3

7.7

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.2

7.6

280

S19

ICPC

Skin injury other

2.1

7.6

360

P17

ICPC

Tobacco abuse

3.7

7.6

SPAT1283

SPAT

Restricted health certificate

1.4

7.6

314

2279

-1, ,

ICPC

2.1

7.6

320

R03BB05

ATC

aclidinium bromide; inhalant

18.4

7.6

Z29.0

ICD-10 Finland

Isolation

18.4

7.6

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.4

7.6

199

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

7.6

268

RK112, ,

NOMESCO Finland

25.1

7.6

SPAT1211

SPAT

Application of soft bandage

1.6

7.5

157

984

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

3.5

7.5

A07AA09

ATC

vancomycin; oral

4.1

7.5

S30.1

ICD-10 Finland

Contusion of abdominal wall

3.2

7.5

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

7.5

328

XG422, ,

SPAT

10.0

7.5

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

7.5

222

1509

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

7.5

444

3427

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.8

7.5

113

649

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

7.5

446

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.9

7.4

114

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

80.3

7.4

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

80.3

7.4

J86.9

ICD-10 Finland

Pyothorax without fistula

80.3

7.4

RS221, ,

NOMESCO Finland

3.6

7.4

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.4

292

2102

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

7.4

337

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

7.4

371

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

7.4

214

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

13.4

7.4

R05CB03

ATC

carbocisteine; oral

2.6

7.4

160

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.3

1165

10234

L50.8

ICD-10 Finland

Other urticaria

3.0

7.3

104

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

7.3

232

1600

E66

ICD-10 Finland

Obesity

1.9

7.3

435

R49.0

ICD-10 Finland

Dysphonia

3.1

7.3

A92

ICPC

Allergy/allergic reaction NOS

2.3

7.3

234

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

7.3

297, ,

Kela drug reimbursment

+∞

7.3

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

7.3

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

7.3

3027

Kela drug reimbursment

Benralizumab

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

7.3

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

7.3

251, ,

Kela drug reimbursment

+∞

7.3

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.3

549

4388

ZXA05

NOMESCO Finland

Left side

1.4

7.3

403

3075

P03

ICPC

Feeling depressed

1.6

7.3

179

1168

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.4

7.3

S01GX06

ATC

emedastine; ophthalmic

3.5

7.3

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.2

7.3

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

7.3

271

1931

C02DE01, ,

ATC

3.8

7.2

J01AA04

ATC

lymecycline; systemic

1.5

7.2

244

1704

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

7.2

254

Z2445

NOMESCO Finland

Psychologist

2.0

7.2

354

I49.5

ICD-10 Finland

Sick sinus syndrome

2.2

7.2

248

B02.9

ICD-10 Finland

Zoster without complication

1.8

7.2

107

612

ZXA00

NOMESCO Finland

Right side

1.4

7.2

435

3366

P25

ICPC

Phase of life problem adult

2.0

7.2

410

XKX00

NOMESCO Finland

Pelvic floor electromyography

7.3

7.2

50708

ICD-8 Finland

Hay fever, Alia definita

7.3

7.2

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

7.2

155

981

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

7.2

301

R4110

NOMESCO Finland

Physiotherapy

1.4

7.2

432

3341

XF404

NOMESCO Finland

Ambulatory ECG

1.7

7.2

129

779

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.1

7.2

L04AA01

ATC

[U] ciclosporin

3.9

7.2

162

Kela drug reimbursment

liraglutide

3.9

7.2

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

7.1

124

741

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

7.1

211

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

20.1

7.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

7.1

162

1038

XQ802

NOMESCO Finland

Epicutan test

2.1

7.1

322

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

4.1

7.1

DFF15

NOMESCO Finland

Speech audiometry

1.9

7.1

491

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

7.0

213

1455

RJ421, ,

NOMESCO Finland

10.0

7.0

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

10.0

7.0

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.3

7.0

238

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

3.1

7.0

N06AA10

ATC

nortriptyline; systemic

2.7

7.0

135

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

7.0

386

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

7.0

201

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.2

7.0

P01BA02

ATC

hydroxychloroquine; oral

1.7

7.0

126

762

N06AX22

ATC

agomelatine; oral

2.6

6.9

147

S87

ICPC

Dermatitis/atopic eczema

2.3

6.9

214

Z01.3

ICD-10 Finland

Examination of blood pressure

3.0

6.9

R43

ICPC

Respiratory, Other diagnostic procedure

7.5

6.9

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

13.8

6.9

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

6.9

148

936

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

6.9

232

1621

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.9

256

1824

D06AX01

ATC

fusidic acid; topical

1.6

6.9

164

1064

A10BK01

ATC

dapagliflozin; oral

1.8

6.8

525

N05AF03

ATC

chlorprothixene; systemic

2.5

6.8

166

H65.0

ICD-10 Finland

Acute serous otitis media

2.8

6.8

114

D09AB01

ATC

zinc bandage without supplements; topical

2.8

6.8

114

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.8

6.8

UDQ22

NOMESCO Finland

Microlaryngoscopy

11.0

6.8

XJC00

NOMESCO Finland

Oesophageal manometry

9.3

6.8

KMAK, ,

NOMESCO Finland

1.3

6.8

988

8571

N02CC06

ATC

eletriptan; oral

2.1

6.8

315

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

40.1

6.8

A06AC51

ATC

ispaghula, combinations; oral

1.9

6.8

405

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

16.7

6.7

S01GX04

ATC

nedocromil; ophthalmic

2.8

6.7

115

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

6.7

182

1214

SPAT1324

SPAT

Screening procedure

1.4

6.7

320

2381

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.9

6.7

R03CC03

ATC

terbutaline; systemic

2.3

6.7

211

J05AB11

ATC

valaciclovir; oral

1.5

6.7

234

1646

A04

ICPC

Weakness/tiredness general

1.4

6.7

252

1798

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

6.7

224

D11AH05

ATC

dupilumab; topical

22.6

6.7

J01

ICD-10 Finland

Acute sinusitis

1.9

6.7

421

S81.0

ICD-10 Finland

Open wound of knee

2.7

6.7

127

L15

ICPC

Knee symptom/complaint

1.3

6.7

420

3268

R04.0

ICD-10 Finland

Epistaxis

1.7

6.7

108

634

T90

ICPC

Diabetes non-insulin dependent

1.4

6.7

362

2753

R97

ICPC

Allergic rhinitis

2.9

6.6

105

N02AJ13

ATC

tramadol and paracetamol; systemic

2.6

6.6

139

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.6

6.6

139

SGA01

NOMESCO Finland

Emergency treatment

1.4

6.6

286

2093

SFA10

NOMESCO Finland

One-surface restoration

1.2

6.6

1084

9523

SPAT1308

SPAT

Sexual health counselling

1.5

6.6

233

1644

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

6.6

374

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

3.8

6.5

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

6.5

123

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.0

6.5

PLAK2, ,

NOMESCO Finland

3.7

6.5

RF212, ,

NOMESCO Finland

6.2

6.5

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.6

6.5

135

ZYC03

NOMESCO Finland

Remote contact, text-based

5.7

6.4

R05DB20

ATC

other cough suppressants - combinations

1.8

6.4

565

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

6.4

129

802

DMB10

NOMESCO Finland

Radical maxillary antrotomy

70.0

6.4

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

70.0

6.4

RJ422, ,

NOMESCO Finland

70.0

6.4

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

70.0

6.4

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

6.4

521

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.2

6.4

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.2

6.4

RJ511, ,

NOMESCO Finland

14.3

6.4

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

14.3

6.4

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

6.4

428

R80

ICPC

Influenza

3.7

6.4

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.1

6.3

262

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.0

6.3

SFA20

NOMESCO Finland

Two-surface restoration

1.2

6.3

1135

10048

M01AH03

ATC

valdecoxib; oral

1.8

6.3

568

B01AF02

ATC

apixaban; oral

1.5

6.3

171

1141

DHA10

NOMESCO Finland

Biopsy of cavity of nose

8.2

6.3

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

3.1

6.3

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.6

6.3

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.2

6.3

217

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

6.0

6.3

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

11.0

6.3

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.4

6.3

167

N06BA04

ATC

methylphenidate; oral

2.0

6.3

331

Z51.88

ICD-10 Finland

Other specified medical care

2.5

6.3

143

C02DE04, ,

ATC

2.2

6.3

224

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

18.1

6.3

N02CD01

ATC

erenumab; parenteral

3.8

6.3

D86.3

ICD-10 Finland

Sarcoidosis of skin

+∞

6.2

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

6.2

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

6.2

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

+∞

6.2

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.2

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

+∞

6.2

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.2

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

6.2

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

+∞

6.2

13597

ICD-8 Finland

Sarcoidosis, Suspecta

+∞

6.2

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.2

1220

FHL

Arthroscopy

2.0

6.2

318

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

6.2

1428

12971

TGD00

NOMESCO Finland

Needle biopsy of lung

26.7

6.2

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

6.2

346

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.0

6.2

305

L17

ICPC

Foot/toe symptom/complaint

1.3

6.2

493

3962

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.2

505

PE1AT

NOMESCO Finland

Femoral artery PTA

5.0

6.2

Z48.8

ICD-10 Finland

Other specified surgical follow-up care

4.0

6.2

L30.0

ICD-10 Finland

Nummular dermatitis

2.0

6.2

299

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

6.2

100

588

C08CA02

ATC

felodipine; oral

1.6

6.1

150

979

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

6.1

297

2216

L01CA04

ATC

vinorelbine; systemic

7.7

6.1

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.1

6.1

246

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

6.1

217

1532

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.2

6.1

220

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.1

1369

12395

Z03

ICPC

Housing/neighbourhood problem

4.1

6.1

SPAT1060

SPAT

Administration of oxygen

12.5

6.1

J38.7

ICD-10 Finland

Other diseases of larynx

12.5

6.1

I95.9

ICD-10 Finland

Hypotension, unspecified

3.0

6.1

L12

ICPC

Hand/finger symptom/complaint

1.4

6.1

275

2029

M10.0

ICD-10 Finland

Idiopathic gout

2.2

6.0

221

EC1VA, ,

NOMESCO Finland

2.0

6.0

315

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

6.0

315

A10BK03

ATC

empagliflozin; oral

1.6

6.0

133

847

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

6.0

364

K78

ICPC

Atrial fibrillation/flutter

1.7

6.0

584

RK110, ,

NOMESCO Finland

6.7

6.0

R23

ICPC

Voice symptom/complaint

2.5

6.0

152

Z10.8

ICD-10 Finland

Routine general health check-up of other defined subpopulations

1.8

6.0

458

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

6.0

371

2876

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.5

6.0

B01AB05

ATC

enoxaparin; parenteral

1.3

6.0

509

4124

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

347

566

6.97

208.26

1.5

1.1

261.60

182.72

u/ml

1.18

334

515

(3023419) Bacteria identified in Sputum by Culture

37.74

146.88

3.1

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

53.63

145.36

1.3

1.0

1.85

3.14

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

377

1095

3.88

112.54

4.2

3.8

0.60

0.79

0.64

307

(3025159) Blasts/100 leukocytes in Blood

360

1014

3.98

112.23

4.2

3.8

0.03

0.49

0.72

230

(3021440) Promyelocytes/100 leukocytes in Blood

369

1059

3.92

112.03

4.2

3.8

0.04

0.10

1.03

269

(3013115) Eosinophils [#/volume] in Blood

1284

7684

2.40

97.24

6.1

5.1

0.22

0.18

e9/l

10.68

1205

6646

(3002179) Metamyelocytes/100 leukocytes in Blood

337

1008

3.71

95.68

3.8

3.6

0.45

0.65

0.59

267

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

53.08

90.72

4.1

2.5

—

(3022096) Basophils/100 leukocytes in Blood

1148

6688

2.34

90.56

5.9

5.1

0.68

0.69

0.31

1111

6139

(3042631) Mycobacterium sp identified in Specimen

18.71

89.15

3.5

2.1

—

(3006504) Eosinophils/100 leukocytes in Blood

1170

6968

2.29

86.43

5.9

5.0

3.12

2.82

3.42

1133

6422

(3019069) Monocytes/100 leukocytes in Blood

1172

7020

2.27

84.96

6.2

5.3

8.48

8.49

0.04

1134

6487

(3001604) Monocytes [#/volume] in Blood

1217

7426

2.26

84.05

5.8

4.9

0.61

0.55

e9/l

17.28

1133

6324

(3006315) Basophils [#/volume] in Blood

1218

7446

2.25

83.60

5.9

4.9

0.04

e9/l

5.04

1133

6335

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

101

113

9.27

82.64

3.1

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1151

6926

2.24

81.52

6.4

5.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

1197

7320

2.23

81.43

6.1

5.1

27.73

29.81

9.86

1162

6793

(3018010) Neutrophils/100 leukocytes in Blood

1183

7221

2.23

80.60

5.8

4.9

57.43

55.73

5.63

1146

6692

(3019198) Lymphocytes [#/volume] in Blood

1244

7756

2.22

80.29

5.8

4.9

2.02

1.97

e9/l

0.24

1178

6772

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

404

1523

2.98

77.82

2.1

1.4

—

(4200892) Spirometry reversibility

226

591

4.11

77.16

1.6

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

12.86

77.08

2.0

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

22.89

76.73

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

116

183

6.60

70.62

1.2

1.0

1.93

1.38

u/ml

0.31

(3000492) Spirometry study

311

1091

3.12

67.51

1.5

1.2

—

(3023368) Bacteria identified in Blood by Culture

603

3008

2.33

64.38

4.3

3.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

114

219

5.41

56.61

1.2

1.1

2.51

2.95

u/ml

0.14

(3013650) Neutrophils [#/volume] in Blood by Automated count

1304

9028

1.94

55.68

8.7

7.4

4.34

3.85

e9/l

13.51

1218

7761

(3021589) Normoblasts [#/volume] in Blood

1109

7393

1.91

51.88

10.5

7.2

0.00

e9/l

1.10

1003

6047

(3014133) Dog dander IgE Ab [Units/volume] in Serum

168

5.84

51.53

1.2

1.0

5.34

3.26

u/ml

0.50

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

627

3444

2.10

51.14

3.2

1.9

1200.72

655.33

ng/l

3.61

533

2864

(3003888) Timothy IgE Ab [Units/volume] in Serum

102

196

5.38

50.61

1.1

1.0

4.70

5.12

u/ml

0.10

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

872

5435

1.93

49.44

3.7

2.7

29.31

47.86

ng/l

1.42

584

3474

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

261

992

2.82

48.47

2.1

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

289

1162

2.68

48.14

2.3

2.0

317.76

380.07

nmol/l

6.95

271

1066

(3008401) Mugwort IgE Ab [Units/volume] in Serum

193

5.24

47.31

1.1

1.0

0.33

2.51

u/ml

1.31

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

258

991

2.79

46.92

2.1

1.4

—

(3021901) Oxygen saturation in Capillary blood

127

5.97

41.38

2.0

2.1

—

(3016502) Oxygen saturation in Arterial blood

248

1050

2.51

36.83

4.8

6.0

94.80

96.71

4.84

234

1009

(3027801) Oxygen [Partial pressure] in Arterial blood

267

1176

2.42

36.39

5.0

5.6

10.89

14.14

kpa

20.98

253

1128

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

267

1178

2.42

36.25

5.0

5.6

5.22

4.99

kpa

3.11

252

1129

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

145

5.23

35.92

1.1

1.0

0.26

0.20

u/ml

0.13

(3017569) Oxygen content in Arterial blood

11.36

35.36

1.7

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

972

6767

1.72

35.24

13.2

10.5

1.23

1.22

inr

0.11

415

1954

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

134

416

3.35

35.17

2.0

1.2

39.43

38.06

u/l

0.30

124

364

(3019060) Gas panel - Arterial blood

173

624

2.91

35.17

3.7

3.9

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

12.22

35.04

1.2

1.1

14.09

20.01

u/ml

0.40

(3023430) Cat dander IgE Ab [Units/volume] in Serum

158

4.93

34.48

1.1

1.0

5.16

3.60

u/ml

0.36

(3003396) Base excess in Arterial blood by calculation

253

1181

2.27

29.99

5.2

5.6

1.94

0.44

mmol/l

8.58

203

922

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

708

4679

1.72

29.97

2.7

2.2

52.74

60.45

u/l

5.30

664

4287

(3005719) IgG [Mass/volume] in Serum or Plasma

208

898

2.44

29.46

2.5

2.1

9.79

10.79

g/l

2.92

200

806

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

505

3042

1.83

29.36

1.9

1.5

0.94

1.16

mg/l

1.46

384

2243

(3013707) Erythrocyte sedimentation rate by Westergren method

1550

12566

1.63

28.56

4.8

3.3

12.73

10.36

mm/h

8.48

1487

11513

(3013826) Glucose [Moles/volume] in Serum or Plasma

1224

9380

1.60

28.47

4.6

3.3

6.42

6.59

mmol/l

2.54

1162

8549

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

8.68

28.40

2.6

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

692

4616

1.69

27.97

3.4

2.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1053

7889

1.58

26.23

5.8

4.9

11.09

11.99

umol/l

1.23

1009

7421

(3009343) pH of Capillary blood

161

652

2.57

26.09

3.8

2.8

7.42

0.18

(3027135) IgG subclass 1 [Mass/volume] in Serum

6.09

25.93

1.7

1.3

6.19

7.35

g/l

1.01

(3024139) IgG subclass 3 [Mass/volume] in Serum

6.09

25.93

1.7

1.3

0.35

0.40

g/l

0.46

(3028192) IgG subclass 2 [Mass/volume] in Serum

6.09

25.93

1.7

1.3

2.53

2.94

g/l

0.93

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

162

660

2.56

25.93

3.8

2.8

5.24

4.99

kpa

3.00

157

626

(4062490) Immunoglobulin typing, IgG

6.01

25.59

1.8

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

161

659

2.54

25.52

5.0

5.6

25.52

24.08

mmol/l

4.11

155

623

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1012

7574

1.57

24.94

6.6

4.8

1.22

mmol/l

0.11

891

6414

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

159

655

2.52

24.86

1.8

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

125

460

2.81

24.45

2.1

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

7.23

23.74

1.4

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

284

3.29

23.70

2.1

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

424

2571

1.78

23.63

1.3

1.2

25.95

29.41

iu/ml

0.30

126

826

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

151

627

2.50

23.21

3.8

2.8

2.62

0.89

mmol/l

7.76

101

434

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

240

1216

2.08

22.97

3.5

3.0

1.23

mmol/l

0.28

225

1019

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

140

4.29

22.81

1.5

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

132

4.40

22.73

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

211

3.58

22.18

1.8

1.1

8.07

9.95

mg/l

1.29

190

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

191

898

2.22

22.12

3.9

1.9

113.31

113.89

ng/l

0.01

171

803

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

319

3.06

21.92

1.6

1.5

105.71

403.00

titre

—

(3037522) Nuclear Ab [Titer] in Serum

327

1878

1.85

21.67

1.5

1.3

386.92

610.47

titre

1.75

363

(3007930) Methemoglobin/Hemoglobin.total in Blood

123

478

2.65

21.66

3.4

0.76

0.90

3.25

114

444

(3007853) Bacteria identified in Skin by Aerobe culture

282

1556

1.92

21.13

1.9

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

119

4.44

21.06

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

119

4.44

21.06

1.3

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

159

714

2.31

20.54

1.7

1.32

1.37

g/l

0.12

151

643

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

175

821

2.22

20.36

1.5

—

(3042936) Bacteria identified in Isolate by Culture

305

1752

1.84

20.13

2.2

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

120

481

2.57

19.87

3.3

3.4

1.93

1.59

1.09

113

448

(3022948) Iron [Moles/volume] in Serum or Plasma

341

2054

1.77

19.17

2.6

2.0

14.32

14.20

umol/l

0.07

322

1892

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

5.20

19.10

1.4

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

109

426

2.63

19.00

2.2

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

198

1015

2.03

18.29

5.5

6.1

123.72

122.29

g/l

0.40

193

984

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

908

6969

1.48

18.23

2.5

2.1

77.54

77.41

nmol/l

0.05

857

6294

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.82

18.00

1.5

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

290

1696

1.80

17.97

2.7

2.1

24.51

24.45

0.02

250

1469

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1519

12889

1.46

17.91

7.6

5.7

76.55

77.66

u/l

0.53

1466

12001

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.77

17.75

1.5

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

308

1842

1.77

17.68

2.6

2.0

2.44

2.36

g/l

1.89

293

1685

(3029937) Albumin [Presence] in Urine by Test strip

637

4577

1.53

17.48

4.1

3.3

0.00

estimate

0.88

319

1463

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

865

6635

1.47

17.15

3.8

3.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

141

3.74

16.83

1.5

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

396

2568

1.65

16.82

3.8

2.6

226.56

518.91

ng/l

1.18

240

1855

(3026493) Urate [Moles/volume] in Serum or Plasma

546

3826

1.55

16.70

2.7

2.2

3345.95

6366.95

umol/l

1.11

507

3386

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

381

2460

1.65

16.44

1.3

1.2

7.41

12.23

u/ml

1.16

208

1025

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.13

15.99

1.6

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

850

6568

1.45

15.93

4.9

3.8

35.34

36.42

g/l

7.10

798

6050

(3026782) Osmolality of Urine

442

2982

1.59

15.89

3.0

2.5

525.38

556.12

mosm/kgh2o

2.15

384

2501

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

103

4.13

15.62

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

103

4.13

15.62

1.4

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

168

3.39

15.61

1.6

1.5

0.61

0.82

g/l

1.16

131

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.63

15.54

1.5

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

629

4605

1.49

15.48

3.3

2.8

71.59

102.36

e6/l

0.38

513

3414

(3044242) Glucose [Moles/volume] in Arterial blood

6.24

15.46

1.5

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

955

7573

1.43

15.40

3.1

2.5

111.59

106.43

ug/l

0.21

907

6999

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

313

2.67

15.03

1.8

1.7

0.81

4.16

ug/l

1.59

265

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

611

4492

1.48

14.60

2.0

1.9

174.43

215.68

u/l

0.72

584

4189

(3021447) Carbon dioxide [Partial pressure] in Venous blood

203

1134

1.86

14.53

3.6

2.9

6.04

5.72

kpa

2.97

195

1104

(44813793) Dust mix specific IgE antibody measurement

4.58

14.46

1.1

1.0

—

(3026008) Bacteria identified in Urine by Culture

664

4978

1.46

14.30

3.0

2.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

333

2.58

14.29

1.4

1.3

—

(1616796) Gas panel - Central venous blood

183

3.16

14.27

2.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

10.48

14.21

4.4

2.8

—

(3000850) Epithelial cells [#/volume] in Urine

443

3090

1.53

13.55

2.5

2.3

5.43

5.87

e6/l

0.42

411

2706

(3025018) Bordetella pertussis Ab [Titer] in Serum

4.81

13.54

1.2

—

(3012441) Differential panel - Pleural fluid

18.31

13.36

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

317

2062

1.62

13.12

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

6.15

12.92

1.0

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

533

3896

1.47

12.90

2.3

2.0

3.06

2.86

mg/l

1.15

475

3268

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

5.62

12.88

1.1

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

5.62

12.88

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

5.62

12.88

1.1

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1335

11419

1.37

12.83

4.5

3.8

192.69

2738.73

e6/l

2.57

143

(3002032) Base excess in Venous blood by calculation

196

1133

1.79

12.55

3.7

2.9

2.32

1.54

mmol/l

1.76

166

927

(3021601) Nitrite [Presence] in Urine by Test strip

1030

8480

1.37

12.50

4.8

4.3

0.00

estimate

-0.00

322

1488

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

669

5129

1.42

12.46

3.1

2.7

33.69

32.76

u/l

0.11

636

4879

(3000494) Fungus identified in Specimen by Culture

260

1639

1.65

12.17

1.4

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

172

969

1.83

11.99

5.9

5.3

1.46

1.38

mmol/l

0.37

165

947

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

307

2.49

11.99

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

13.43

11.93

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1036

8584

1.36

11.88

3.7

3.2

0.00

0.01

estimate

0.40

308

1468

(3012095) Magnesium [Moles/volume] in Serum or Plasma

300

1976

1.59

11.74

3.2

2.7

0.82

0.83

mmol/l

0.33

281

1834

(3026389) Candida sp identified in Specimen by Organism specific culture

189

2.90

11.71

1.5

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

5.54

11.64

1.1

1.72

7.30

u/ml

0.56

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1582

14013

1.36

11.52

4.0

3.7

14.85

14.66

pmol/l

2.31

1475

12670

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1980

18205

1.44

11.48

16.7

8.7

18.89

21.60

mg/l

3.95

1713

13260

(3035350) Ketones [Presence] in Urine by Test strip

1023

8497

1.35

11.39

3.7

3.2

0.00

estimate

1.71

334

1589

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

17.10

11.18

1.4

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

4.18

11.06

1.1

1.0

4.74

16.94

iu/ml

1.57

(3018095) Leukocytes [#/volume] in Urine

713

5619

1.38

11.05

3.9

3.1

86.88

114.00

e6/l

0.50

552

3720

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

699

5496

1.38

10.97

3.3

2.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.67

10.94

1.8

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

443

3217

1.46

10.91

1.5

1.3

2.33

2.26

g/l

0.43

330

1923

(3015171) Extractable nuclear Ab [Units/volume] in Serum

101

495

2.08

10.59

1.3

1.2

0.19

0.97

u/ml

—

(3047181) Lactate [Moles/volume] in Blood

345

2.30

10.54

4.9

4.1

1.20

1.25

mmol/l

0.29

292

(3010421) pH of Blood

259

2.51

10.51

4.2

2.0

7.43

7.41

2.74

246

(40767503) Oxygen content in Capillary blood by calculation

168

2.89

10.44

1.8

1.7

17.52

17.48

0.02

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.09

10.41

1.8

2.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

314

2.33

10.07

1.2

—

(3039000) Anion gap in Blood

235

2.55

10.03

4.7

5.0

11.09

11.36

mmol/l

0.22

204

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

110

569

1.98

9.97

6.6

7.0

—

(3018572) Chloride [Moles/volume] in Blood

236

2.54

9.95

4.7

4.9

103.59

105.84

mmol/l

3.18

205

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

273

2.42

9.89

1.2

1.4

—

12.74

—

(3022313) Gas panel - Capillary blood

100

510

2.00

9.44

3.9

2.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

250

1660

1.56

9.41

5.8

4.1

1.10

1.03

mmol/l

2.95

230

1532

(3022145) Colonoscopy Study observation

258

1727

1.55

9.37

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.97

9.31

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

158

2.82

9.17

1.3

1.4

266.46

295.84

pmol/l

0.31

138

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

8.31

9.05

1.5

1.1

—

(3045788) Cell count panel - Pleural fluid

15.64

9.02

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1339

11793

1.30

8.97

3.5

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

318

2.24

8.93

1.6

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

144

2.88

8.91

1.4

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.90

8.83

1.6

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

161

975

1.70

8.78

3.8

2.5

5.00

4.52

kpa

1.03

154

949

(3047007) Chlamydophila sp Ab [Presence] in Serum

158

2.75

8.61

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

666

5369

1.33

8.50

3.0

2.8

2.35

2.36

mmol/l

1.39

598

4703

(3045424) Erythrocytes [Presence] in Urine

244

2.37

8.37

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

462

3531

1.38

8.34

1.7

1.6

64179549.50

42735175.79

pmol/l

0.27

402

2918

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

+∞

8.33

1.5

0.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

129

2.90

8.17

3.2

2.5

0.79

0.75

nmol/l

0.20

(3020630) Protein [Mass/volume] in Serum or Plasma

150

910

1.69

8.14

1.8

2.0

67.28

67.47

g/l

0.13

135

798

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

808

6727

1.30

8.09

6.2

4.3

1.22

mmol/l

0.83

749

6051

(3012501) Base excess in Blood by calculation

217

2.43

8.08

4.6

2.1

2.38

2.19

mmol/l

0.19

116

(3037467) Urinalysis macro (dipstick) panel - Urine

1355

12044

1.28

8.03

4.4

3.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

8.94

8.03

1.6

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

8.94

8.03

1.6

1.2

—

(3044889) 12 lead EKG panel

1357

12094

1.27

7.74

3.7

3.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

2.68

7.64

1.2

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

228

1554

1.51

7.61

5.3

5.2

104.04

104.89

mmol/l

1.95

228

1554

(3020779) Urea [Moles/volume] in Serum or Plasma

158

994

1.63

7.48

7.1

5.1

9.72

8.67

mmol/l

1.14

152

941

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

201

2.41

7.43

1.1

14.08

7.66

au/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.84

7.28

1.1

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.84

7.28

1.1

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.24

7.23

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

231

2.28

7.07

1.7

2.3

—

(3030467) Casts [#/volume] in Urine by Automated count

524

4179

1.32

7.04

3.1

2.7

0.56

0.36

e6/l

1.03

420

3104

(3004588) Protein electrophoresis panel - Serum or Plasma

133

815

1.67

6.99

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

298

2.11

6.95

3.4

2.7

0.37

0.36

u/ml

0.11

153

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1838

17115

1.29

6.80

14.6

9.1

83.99

83.02

ml/min/173m2

1.07

1611

13638

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

9.32

6.78

1.3

1.1

14.15

13.86

u/l

0.04

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

3.23

6.69

1.5

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

3.23

6.69

1.5

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

195

1325

1.51

6.62

2.4

2.1

0.21

0.22

g/l

0.96

184

1234

(3025941) Bacteria identified in Stool by Culture

136

853

1.63

6.55

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

267

2.12

6.44

3.2

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

223

2.22

6.32

1.5

2.0

138.86

132.50

g/l

0.85

168

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.67

6.19

1.4

1.3

—

(3018418) pH of Serum or Plasma

529

4295

1.29

6.15

4.5

3.0

7.39

7.40

0.69

143

768

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.41

6.13

1.6

1.4

—

0.82

—

(21494815) CD4 cells/100 lymphocytes in Specimen

3.10

6.04

1.3

2.2

40.17

40.93

0.08

(42529582) MDA5 Ab [Presence] in Serum by Line blot

6.70

6.03

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

6.70

6.03

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

6.70

6.03

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

6.70

6.03

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

117

2.67

5.99

1.6

1.4

33.00

27.26

0.27

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

373

1.90

5.95

2.0

817.51

1226.40

ug/l

0.19

352

(3048689) Calprotectin [Mass/mass] in Stool

274

2033

1.39

5.85

2.4

2.3

123.63

126.41

ug/g

0.05

210

1594

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

5.36

5.84

1.3

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

127

807

1.60

5.83

1.4

1.3

21.92

27.09

iu/l

1.18

111

673

(36304419) Bacteria [Presence] in Urine

503

4087

1.29

5.78

3.1

2.6

—

(40758558) Short blood count panel - Blood

477

3854

1.29

5.72

7.1

5.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

166

1126

1.51

5.71

2.4

2.0

11.62

11.86

nmol/l

0.15

141

1004

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.92

5.71

1.4

1.7

123.55

141.28

umol/l

0.13

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

195

2.23

5.63

5.4

3.6

175.86

342.33

iu/ml

—

(3020891) Body temperature

464

1.77

5.49

4.8

3.6

—

(3000034) Microalbumin [Mass/volume] in Urine

129

2.50

5.45

3.2

2.8

50.56

12.22

mg/l

0.54

(3048929) Epstein Barr virus Ab [Presence] in Serum

429

1.80

5.42

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

372

1.85

5.36

1.7

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

323

1.91

5.32

1.9

2.1

3.20

1.89

ratio

0.38

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1281

11638

1.21

5.10

3.1

2.6

47.27

40.71

u/l

2.39

1221

10888

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

3.02

5.10

1.1

1.2

1.12

7.33

nmol/l

—

(3003338) MCHC [Mass/volume]

1523

16328

0.82

5.06

19.1

12.4

331.71

332.88

g/l

5.24

1510

16175

(3018677) aPTT in Platelet poor plasma by Coagulation assay

272

2066

1.36

5.03

2.2

1.8

29.27

29.32

0.06

266

2005

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

602

1.64

4.94

2.0

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1976

18780

1.26

4.93

17.2

10.6

3.96

mmol/l

0.12

1946

18127

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

147

1005

1.49

4.91

3.6

3.1

92.24

76.34

ng/l

1.13

124

869

(3004809) Band form neutrophils/100 leukocytes in Blood

174

2.20

4.90

3.6

3.3

3.15

1.25

0.82

155

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

334

1.85

4.83

2.0

2.1

28.41

54.31

mg/l

0.88

277

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.00

4.82

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

335

1.84

4.79

1.9

2.1

63.90

41.86

mg/l

0.66

273

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

401

1.77

4.79

1.6

0.17

0.16

iu/ml

0.03

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

5.73

4.75

1.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1968

18718

1.25

4.74

17.0

10.6

139.53

139.80

mmol/l

4.91

1938

18106

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

151

2131

0.69

4.69

6.5

5.7

—

(40768804) Tissue Pathology biopsy report

798

6971

1.21

4.67

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

393

3177

1.28

4.65

1.7

1.4

—

(3013512) EKG study

550

4634

1.24

4.56

4.1

3.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.60

4.47

1.9

3.75

2.53

u/field

0.18

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

300

2357

1.31

4.41

3.2

2.5

4.81

2.63

e6/l

1.92

193

1283

(3014599) Egg white IgE Ab [Units/volume] in Serum

2.63

4.39

1.0

0.62

0.38

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

289

1.85

4.29

1.3

1.2

—

(1002224) Polysomnography panel

587

1.59

4.24

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

455

1.67

4.22

1.9

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

455

1.67

4.22

1.9

1.5

7.40

7.35

g/l

0.10

403

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

455

1.67

4.22

1.9

1.5

3.60

3.71

g/l

0.29

404

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.43

4.18

3.1

1.7

542.21

1452.59

u/ml

0.90

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

469

3920

1.24

4.16

1.2

1.3

2.04

1.73

u/ml

0.19

168

1035

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

355

2878

1.27

4.09

3.2

2.7

2.46

2.44

mmol/l

1.26

311

2503

(3024891) Influenza virus A+B Ag [Presence] in Specimen

287

1.83

4.07

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

2.64

4.06

1.0

0.80

5.42

u/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

354

1.74

4.05

3.6

4.0

1.48

1.30

mg/l

1.15

326

(3021960) Folate [Moles/volume] in Serum or Plasma

440

3663

1.24

4.04

1.5

1.4

20.52

21.18

nmol/l

0.39

399

3116

(3002079) Sodium [Moles/time] in 24 hour Urine

3.03

3.96

1.3

191.97

157.93

mmol/24h

0.85

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

343

1.74

3.90

1.6

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

145

2.15

3.86

2.7

3.7

17.00

34.29

u/ml

1.49

145

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

422

1.65

3.80

2.0

1.5

2.72

2.96

g/l

1.20

371

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

134

949

1.44

3.80

3.1

3.4

4.39

4.53

pmol/l

1.17

126

835

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

130

1811

0.70

3.79

1.5

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

153

2.11

3.78

1.8

1.6

67.63

61.27

0.44

(3008536) Aspergillus sp Ab [Presence] in Serum

12.02

3.76

1.3

2.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.60

3.74

1.3

2.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

387

1.67

3.69

2.1

1.6

0.50

0.83

g/l

0.48

329

(3022689) Creatine [Moles/volume] in Urine

3.05

3.52

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.43

3.47

1.0

1.1

1.28

0.46

u/ml

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

160

2.01

3.39

1.3

—

nmol/l

—

(3011897) Casein IgE Ab [Units/volume] in Serum

5.01

3.37

1.1

1.2

0.69

2.84

u/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.33

3.33

1.1

1.3

65.32

79.91

umol/l

3.21

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

322

1.69

3.31

1.4

1.5

324.71

11602.96

e6/l

0.51

267

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.36

3.30

2.2

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

115

2.19

3.28

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

103

717

1.46

3.24

1.9

1.8

—

(3000991) Gas panel - Venous blood

133

973

1.39

3.19

6.1

5.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.80

3.18

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1781

16982

1.17

3.16

4.8

4.3

1.91

2.10

mu/l

0.74

1681

15507

(46235355) HIV 1 and 2 tests - Meaningful Use set

418

3554

1.21

3.11

1.8

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

146

2.00

3.05

1.0

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

906

8235

1.16

3.04

2.6

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

168

1.92

2.99

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

237

1903

1.27

2.99

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

1635

1.29

2.97

2.8

2.3

8.82

8.47

umol/l

0.08

180

1403

(3023520) Reticulocytes [#/volume] in Blood

144

1082

1.35

2.94

2.1

2.4

73.57

65.87

e9/l

1.80

119

803

(3009508) Creatinine [Moles/volume] in Urine

576

5067

1.18

2.93

2.9

3.0

7.82

7.57

mmol/l

0.60

513

4312

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

674

0.59

2.90

1.2

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

189

1481

1.30

2.89

2.5

2.3

1.78

1.67

0.78

173

1297

(3052592) Norovirus Ag [Presence] in Stool

5.39

2.87

2.3

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

6.68

2.86

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.26

2.86

1.4

—

(3019977) pH of Arterial blood

3.17

2.85

2.4

1.8

7.38

7.41

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1219

0.69

2.82

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

268

1.69

2.82

1.4

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

322

1.63

2.81

1.2

1.5

32.65

20.76

e6/l

0.25

251

(3000060) B lymphocytes [#/volume] in Blood

3.34

2.81

2.0

1.9

435.00

233.08

e6/l

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.65

2.79

2.4

2.3

82.14

100.87

1.63

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1721

16432

1.16

2.75

5.5

5.0

39.61

38.81

mmol/mol

3.49

1640

15166

(3023511) Choriogonadotropin [Units/volume] in Urine

397

1.55

2.70

1.6

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

326

1.61

2.69

2.2

1.47

1.60

mmol/l

0.46

315

(3002385) Erythrocyte distribution width [Ratio]

1688

16116

1.15

2.63

19.9

11.5

17.03

14.70

0.45

1671

15740

(3009214) Lutropin [Units/volume] in Serum or Plasma

489

1.49

2.63

1.6

1.4

8.60

8.72

u/l

0.03

396

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

226

1837

1.25

2.60

1.5

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.68

2.59

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.06

2.56

2.2

3.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.06

2.56

1.3

2.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

215

1.73

2.55

3.1

3.6

4.07

3.58

e9/l

1.16

215

(21494755) Public health laboratory ask at order entry panel

233

1907

1.24

2.52

1.3

—

(3037756) Immunofixation for Serum or Plasma

216

1.72

2.52

1.3

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

404

1.52

2.52

1.1

1.2

53.33

70.57

titre

—

(3005570) Glucose [Moles/volume] in Urine

179

1.80

2.51

2.2

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

317

1.59

2.49

1.2

1.3

3.59

3.64

mmol/l

0.12

297

(3003327) Ova and parasites identified in Stool by Light microscopy

504

1.46

2.47

1.4

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

166

2086

0.78

2.47

4.3

32.17

32.69

0.24

115

1388

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

326

1.58

2.46

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

243

2009

1.23

2.41

1.7

1.50

1.38

1.66

214

1800

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

368

1.53

2.41

1.3

490.84

511.68

mg/l

0.12

346

(3003181) Sodium [Moles/volume] in Urine

182

1.77

2.39

1.3

66.60

67.73

mmol/l

0.06

150

(3024932) HLA-DR beta [Type]

3.34

2.39

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

426

1.49

2.38

2.1

1.5

10.11

10.42

g/l

0.22

370

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

517

1.44

2.37

1.4

1.7

1.57

1.47

g/l

0.45

444

(3034274) Bile acid [Moles/volume] in Serum --fasting

259

1.63

2.36

1.8

2.3

5.63

8.80

umol/l

0.66

189

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

569

1.42

2.33

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.13

2.28

1.4

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

738

6724

1.14

2.27

1.9

1.8

97.11

96.95

pmol/l

0.03

413

3418

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.62

2.27

1.7

1.0

95.67

91.92

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

618

0.62

2.27

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

3.48

2.27

4.0

3.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

216

1.68

2.25

1.7

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.90

2.25

1.3

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.90

2.25

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.90

2.25

1.3

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

271

2286

1.21

2.22

2.1

2.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

225

1.65

2.21

3.2

3.8

58.38

56.74

0.41

225

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.46

2.10

2.3

2.6

40.71

38.69

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

190

1557

1.24

2.07

3.3

3.8

5.12

45.43

ug/l

1.16

166

1243

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

357

1.49

2.07

2.1

2.2

116.33

88.08

ug/min

0.22

205

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

140

1107

1.28

2.07

2.1

2.0

4.19

6.95

ug/l

3.13

124

958

(3000570) Elastase.pancreatic [Mass/mass] in Stool

390

1.47

2.07

1.5

1.4

314.92

291.03

ug/g

0.42

209

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.03

2.05

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.51

2.05

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

103

1.95

2.05

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

134

1057

1.28

2.03

2.2

2.3

41.30

21.97

au/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.11

2.02

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

217

1.62

1.97

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.57

1.94

1.0

—

(3024471) HLA-A [Type]

2.97

1.93

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.75

1.93

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

135

1.78

1.91

4.5

3.5

8.09

6.84

mmol/l

0.35

114

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.06

1.90

1.0

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

537

4847

1.14

1.88

3.4

3.7

7.49

6.29

mg/mmol

0.30

370

2950

(3021879) Hepatitis B virus core Ab [Presence] in Serum

148

1195

1.25

1.87

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

114

1.85

1.87

1.3

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.65

1.86

1.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

586

1.36

1.86

4.5

2.2

1.49

1.22

0.97

577

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

237

1.57

1.84

1.2

1.3

20.51

22.74

u/l

0.20

205

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

152

1.72

1.83

1.8

2.0

1.10

1.88

u/field

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

501

0.63

1.82

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

4.17

1.82

1.6

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

254

1.54

1.81

1.5

1.3

103.75

107.65

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.06

1.80

1.3

1.1

—

(3017732) Neutrophils [#/volume] in Blood

132

1057

1.26

1.80

2.9

2.7

5.12

5.37

e9/l

0.09

110

864

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.05

1.80

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

109

853

1.29

1.78

1.1

138.33

149.19

titre

—

(3019309) Folate [Moles/volume] in Red Blood Cells

320

2796

1.17

1.78

1.6

1.7

1262.89

1152.15

nmol/l

1.26

253

2109

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

292

2535

1.17

1.76

2.2

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

185

1.63

1.75

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.34

1.74

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.92

1.72

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.85

1.71

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

348

1.45

1.71

1.2

1.3

2.47

6.69

u/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

133

1.74

1.69

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.96

1.69

1.1

1.0

1.07

1.17

u/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

275

1.50

1.69

1.3

1.5

—

(40768443) Skin Pathology biopsy report

676

1.31

1.67

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

694

1.31

1.66

1.6

284.79

297.20

mu/l

0.17

633

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.51

1.66

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.10

1.65

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

101

793

1.28

1.64

2.1

1.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.58

1.61

39.4

6.1

5.12

6.14

mmol/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

361

1.42

1.61

2.3

1.5

39.50

38.42

g/l

0.64

307

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.15

1.61

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.91

1.59

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

106

1.80

1.58

1.2

—

(3019150) Specific gravity of Urine by Refractometry

423

3807

1.13

1.56

3.9

3.5

1.02

kg/l

0.61

562

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

248

1.50

1.55

1.1

2.22

3.53

u/ml

0.37

117

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.89

1.54

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.89

1.54

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

158

0.44

1.54

1.1

379.86

357.72

nmol/l

—

140

(3036489) Thrombin time

493

1.35

1.53

3.1

1.8

21.46

20.92

0.27

420

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1218

0.79

1.52

1.5

—

(4035726) Immunohistochemistry procedure

156

1300

1.21

1.52

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

102

811

1.27

1.52

2.1

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

225

1.52

1.51

1.1

—

(3000012) Reticulocyte production index

185

1.57

1.51

1.2

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

146

1.65

1.50

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.16

1.50

7.5

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

101

804

1.27

1.49

2.1

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

317

1.43

1.48

1.7

1.6

8301.03

13860.81

e6/l

0.75

226

(3004451) EKG impression Narrative

2.44

1.48

1.6

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

276

1.46

1.47

1.2

14.56

1.85

u/ml

—

(3038515) Glucose [Moles/volume] in Venous blood

310

1.43

1.45

2.3

7.08

7.58

mmol/l

0.80

302

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.45

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.45

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

144

1197

1.22

1.45

1.2

126.42

140.98

iu/ml

0.17

459

(3005011) Chlamydia sp Ab [Titer] in Serum

3.13

1.44

1.2

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.13

1.44

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

228

1.50

1.43

1.2

1.3

5.82

4.58

u/ml

0.10

(3027008) Opiates [Presence] in Urine

101

809

1.26

1.43

2.1

1.8

—

(3012516) Albumin [Mass/volume] in Urine

501

4581

1.12

1.42

2.8

3.1

422.69

222.09

mg/l

0.43

333

2757

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.25

1.40

1.1

—

(3016879) Cocaine [Presence] in Urine

742

1.26

1.37

2.0

1.9

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.61

1.36

1.2

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.94

1.36

1.0

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

207

1.50

1.35

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.76

1.34

1.1

1.09

1.03

ratio

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

146

1226

1.20

1.34

2.6

2.2

69.99

69.50

ml/min/173m2

0.06

470

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.87

1.34

1.4

—

93.33

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

216

1.49

1.33

1.2

1.3

3.20

3.51

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

358

3961

0.89

1.32

3.7

3.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.50

1.30

1.5

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.30

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.78

1.28

1.8

1.9

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.09

1.27

2.1

7.33

9.08

mg/l

—

(3011288) Drugs identified in Urine by Screen method

545

1.29

1.27

2.8

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

154

1.56

1.25

1.4

1.3

—

(40761511) CBC panel - Blood by Automated count

1996

19547

1.11

1.24

15.1

9.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.40

1.24

1.5

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.40

1.24

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

100

1.70

1.23

1.3

161.01

281.73

pmol/l

0.68

100

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

100

1.70

1.23

2.1

1.4

20.00

20.50

u/ml

—

(4281824) Cell count and differential, peritoneal fluid

187

0.53

1.19

1.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.88

1.18

1.1

1.0

131.92

226.88

iu/ml

1.09

(3013139) Helicobacter pylori Ag [Presence] in Stool

133

1124

1.19

1.17

1.2

—

(3008898) HLA-B27 [Presence]

561

1.27

1.17

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

579

1.27

1.16

3.7

2.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.50

1.15

1.2

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.50

1.15

1.2

1.1

—

(40768441) Liver Pathology biopsy report

118

1.61

1.14

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

178

1546

1.16

1.14

3.4

2.6

—

(3034426) Prothrombin time (PT)

2.00

1.12

1.4

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.26

1.10

1.1

96.97

36.65

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

407

1.31

1.09

1.9

2.0

2.33

5.08

iu/l

2.97

160

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

570

0.75

1.09

1.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

793

1.22

1.09

2.6

2.0

5567.89

5999.62

u/l

0.05

330

(3024263) Appearance of Synovial fluid

1.82

1.08

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

2.19

1.08

1.1

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

167

1453

1.16

1.06

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

580

1.25

1.03

4.5

2.2

0.62

0.65

0.44

573

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.27

1.03

1.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.64

1.03

2.2

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

439

1.28

1.01

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

115

1.57

0.99

1.1

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.18

0.98

3.6

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.18

0.98

3.6

1.7

—

(40761535) Cells panel - Urine sediment

112

1312

0.85

0.97

3.7

3.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

442

1.27

0.97

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

108

1.58

0.96

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

116

0.52

0.94

1.0

71.83

47.40

ng/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

436

1.27

0.93

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

146

0.55

0.92

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

1.82

0.92

2.7

2.5

—

(3003694) ABO and Rh group [Type] in Blood

516

5496

0.92

0.91

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

176

1.42

0.90

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

118

1015

1.17

0.90

1.8

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.91

0.88

1.0

1.9

44.90

117.94

nmol/24h

—

(3047189) Immunofixation for 24 hour Urine

1.86

0.87

1.4

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

281

1.32

0.86

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

477

1.24

0.86

1.1

1.54

5.44

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

264

1.33

0.86

1.3

1.2

245.70

233.39

u/ml

0.13

150

(3043410) Blood group antigens tested for on Red Blood Cells

1.82

0.85

1.8

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

557

5248

1.08

0.85

2.6

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

317

1.30

0.85

3.3

2.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

501

0.77

0.83

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

512

0.78

0.83

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.76

0.83

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.76

0.83

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

114

0.52

0.82

1.0

545.50

353.71

ng/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.74

0.82

1.4

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.74

0.82

1.0

1.1

—

(3015736) pH of Urine

717

6829

1.07

0.81

3.2

3.0

5.88

5.92

0.13

551

(3005033) Fetal Nuchal fold Thickness US

498

0.78

0.80

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

794

0.83

0.80

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.82

0.79

1.3

2.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

173

1.39

0.78

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.78

0.0

2.4

—

159.92

—

(40768800) Prostate Pathology biopsy report

327

0.73

0.78

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

428

4558

0.93

0.76

1.5

1.6

1.48

1.30

mmol/l

3.52

376

3834

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

319

2954

1.09

0.75

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2014

19851

1.08

0.74

10.4

8.0

28.53

25.16

u/l

2.37

1971

19004

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

436

0.78

0.74

1.6

1.4

62.99

140.69

pmol/l

1.40

426

(1001926) Buprenorphine [Presence] in Urine by Screen method

626

1.19

0.72

2.7

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

131

1163

1.13

0.69

1.7

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.64

0.68

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

266

1.28

0.68

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

293

1.27

0.68

1.1

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

110

967

1.14

0.68

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

196

1.33

0.67

2.6

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

120

0.58

0.67

1.0

1.3

—

(3028433) Virus identified in Specimen by Culture

1.79

0.66

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

504

1.19

0.65

3.7

2.8

0.23

g/l

0.02

187

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.48

0.64

1.1

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

611

0.83

0.63

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

610

0.83

0.62

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

608

0.84

0.61

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

608

0.84

0.61

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

148

1.35

0.59

1.4

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.53

0.59

1.4

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

114

1.41

0.58

4.7

3.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.56

0.58

1.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

219

1.28

0.58

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

175

1.32

0.58

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.62

0.55

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

296

0.77

0.55

1.2

—

(3051651) Icteric interference index of Serum or Plasma

1.54

0.55

3.4

3.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.45

0.55

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.45

0.55

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

1.58

0.54

1.3

1.6

—

(40768795) Lymph node Pathology biopsy report

147

0.68

0.53

1.5

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.52

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.50

0.51

1.8

1.1

54.50

61.74

—

(4034850) Laboratory test

556

1.15

0.50

6.6

8.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.46

0.50

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

172

1.28

0.48

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

729

0.87

0.47

1.5

1.4

3.01

2.80

mg/l

0.09

502

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1755

17312

1.05

0.47

3.7

3.6

1.33

1.23

mmol/l

5.82

1653

15859

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.46

0.46

1.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.46

0.46

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

695

6723

1.05

0.46

2.4

2.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

173

1.27

0.46

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

173

1.27

0.46

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.62

0.45

1.4

1.2

—

(3036603) Volume of Urine

1.43

0.45

1.4

1.3

1849.82

1784.84

0.09

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.40

0.45

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1797

17745

1.05

0.44

4.3

4.1

5.87

5.81

mmol/l

1.19

1695

16109

(3044927) Protein electrophoresis panel - Urine

121

1.32

0.44

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

121

1.32

0.44

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.37

0.43

1.2

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

211

1.23

0.43

1.5

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.61

0.43

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

331

1.18

0.42

1.5

2.0

0.85

0.71

nmol/l

0.64

277

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.63

0.42

1.5

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.36

0.41

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.52

0.41

4.4

2.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.41

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.36

0.41

1.6

2.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

145

1344

1.08

0.40

2.6

2.2

29.81

78.94

u/l

0.78

124

1150

(4094501) Cardiovascular stress test using bicycle ergometer

408

1.15

0.40

1.1

—

(3045142) Bone marrow Pathology biopsy report

150

1.27

0.40

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

241

1.21

0.40

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

102

0.69

0.39

1.4

2.1

0.60

3.27

ug/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

674

1.12

0.39

1.4

—

(3025130) Human papilloma virus identified in Specimen

269

0.82

0.38

1.5

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.38

0.38

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.38

0.38

1.1

1505.45

1590.64

miu/ml

0.11

(3051101) Glucose [Moles/volume] in Cord blood

1.35

0.37

5.6

6.0

—

(3033799) Differential panel - Peritoneal fluid

1.35

0.37

2.6

1.9

—

(3024928) Oxygen saturation in Venous blood

235

1.19

0.36

7.1

2.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.33

0.35

1.2

1.1

—

(3002256) Pathology report gross observation

215

2269

0.94

0.35

1.3

—

(21494434) Karyotype in Bone marrow

126

1.27

0.35

1.6

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

434

1.13

0.33

3.6

3.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

127

1.26

0.33

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

176

0.79

0.32

3.4

1.9

37.40

23.96

mg/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

128

1.25

0.31

2.5

2.3

1.05

1.61

g/24h

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

211

1.19

0.31

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

858

1.09

0.31

3.4

3.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

120

1.25

0.30

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.25

0.29

1.1

1.5

—

(40768793) Breast Pathology biopsy report

407

0.88

0.28

1.2

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

408

3956

1.04

0.27

2.3

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

615

1.09

0.26

1.3

167.93

218.13

miu/ml

0.94

292

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

276

2865

0.96

0.26

2.9

3.1

0.74

0.84

ug/l

1.11

166

1910

(3022621) pH of Urine by Test strip

121

1141

1.06

0.25

2.8

2.7

—

(3006653) Thiamine [Moles/volume] in Blood

1.18

0.24

1.0

1.1

152.66

131.80

nmol/l

—

(3036180) Methadone [Presence] in Urine

1.18

0.24

7.7

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

312

1.12

0.24

1.4

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

446

1.10

0.23

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

341

1.12

0.23

1.2

—

(40761536) Microorganisms panel - Urine sediment

136

1429

0.95

0.22

4.5

3.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.76

0.22

1.6

1.2

—

(3048879) Bone marrow aspiration report

1.25

0.22

1.0

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.19

0.21

1.4

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.19

0.21

1.0

1.2

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

3.00

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

8.30

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

1.9

—

2072.73

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

260

2515

1.04

0.21

3.0

2.4

2.53

1.38

e6/l

0.38

152

1431

(3035320) C reactive protein [Mass/volume] in Body fluid

101

0.79

0.21

3.6

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.16

0.21

1.4

1.3

7.57

9.33

ug/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.16

0.21

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

1.22

0.20

1.2

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

118

1.19

0.19

1.7

1.4

25.85

31.18

nmol/l

0.49

103

(3029396) Erythrocyte agglutination [Presence] in Blood

1.17

0.17

3.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.21

0.17

1.2

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.76

0.17

1.4

1.2

—

(4146454) Self-monitoring of blood glucose

173

0.87

0.16

2.3

2.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

288

0.90

0.16

3.4

2.9

34.78

28.86

u/ml

0.16

279

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

288

0.90

0.16

1.3

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

823

0.95

0.16

2.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

101

1.19

0.16

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.11

0.16

1.9

2.0

—

158.75

—

(3039443) Prostate specific Ag panel - Serum or Plasma

266

0.90

0.15

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

264

1.10

0.15

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

264

1.10

0.15

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.15

0.15

1.0

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

398

0.93

0.14

3.0

2.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

210

2044

1.03

0.14

1.8

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

319

3255

0.98

0.14

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

1.19

0.14

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

377

0.93

0.13

4.5

2.9

28.58

26.94

mg/l

0.08

227

(3033658) Prothrombin time (PT) actual/Normal

394

3869

1.02

0.13

4.0

3.0

91.99

92.28

0.08

383

3766

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

540

0.94

0.13

2.3

3.2

50.70

900.29

u/ml

1.37

453

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1859

18508

1.02

0.12

4.4

2.73

2.80

mmol/l

2.91

1760

17068

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

210

1.10

0.12

1.5

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

389

3951

0.98

0.12

4.2

4.5

20.94

22.31

0.97

167

1992

(3019225) pH of Specimen

162

1578

1.03

0.11

3.3

3.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

280

1.07

0.10

1.0

1.1

1.70

1933.10

iu/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.09

0.09

1.0

1.1

—

(3017704) Immunofixation for Urine

1.05

0.08

1.2

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

107

1.12

0.08

1.3

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

146

1.10

0.08

1.3

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.77

0.08

3.8

2.6

49.18

52.05

umol/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.09

0.08

1.6

2.0

—

(36660697) Celiac disease serology panel - Serum

137

1400

0.98

0.08

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

493

4881

1.01

0.08

4.8

5.1

2.88

4.38

ug/l

0.88

451

4378

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

147

1.09

0.07

2.4

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.12

0.06

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1824

18188

1.01

0.06

4.1

4.0

4.65

4.71

mmol/l

2.03

1733

16892

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

162

0.93

0.06

1.3

1.5

—

(3044941) Cell count panel - Synovial fluid

211

0.95

0.04

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

2127

21287

0.99

0.04

22.8

14.4

135.67

135.64

g/l

0.04

2113

20913

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

489

1.02

0.03

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1807

18042

1.00

0.02

4.0

1.48

1.50

mmol/l

1.49

1717

16665

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

639

1.02

0.02

1.8

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

142

1.06

0.02

1.0

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

182

1.04

0.02

2.1

1.9

—

(3026361) Erythrocytes [#/volume] in Blood

2127

21277

0.99

0.02

22.6

14.3

4.53

4.51

e12/l

0.97

2097

20550

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

969

1.01

0.02

1.1

1.0

—

(3011648) Oxygen content in Venous blood

1.08

0.02

15.0

3.1

10.57

11.24

—

(3024731) MCV [Entitic volume]

2127

21275

1.00

0.01

22.5

14.3

90.77

90.62

0.76

2110

20893

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

528

0.98

0.01

2.0

1.7

—

(3035941) MCH [Entitic mass]

2127

21274

1.00

0.01

22.5

14.2

30.12

30.24

2.23

2110

20891

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

277

0.97

0.01

1.4

0.29

0.38

nmol/l

0.51

226

(3007461) Platelets [#/volume] in Blood

2127

21253

1.00

0.01

22.6

14.3

264.55

250.86

e9/l

16.73

2097

20575

(3019832) Treponema pallidum Ab [Presence] in Serum

222

2211

1.00

0.01

1.5

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

154

1.04

0.00

1.9

2.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

2125

21236

1.00

0.00

22.3

14.3

40.79

40.31

1.21

2020

19809

(3032773) Endomysium IgG Ab [Titer] in Serum

154

0.97

0.00

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

141

0.99

0.00

3.2

3.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

103

0.97

0.00

5.7

7.0

—

(3010813) Leukocytes [#/volume] in Blood

2128

21277

1.00

0.00

22.6

14.3

7.18

6.52

e9/l

20.70

2098

20542

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

653

0.99

0.00

1.3

1.5

—

(3021788) Differential panel - Synovial fluid

232

0.99

0.00

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.89

0.00

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

2.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.90

-0.00

2.0

2.7

46512.50

40150.70

ug/l

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.88

-0.00

2.7

4.0

—

83.56

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.85

-0.00

1.0

1.1

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.85

-0.00

8.8

4.2

7.13

8.44

mg/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

0.92

-0.00

8.3

11.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

7.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

284.43

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.91

-0.00

1.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.5

—

3.30

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_MIXED_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_MIXED_EXMORE	1.854 [1.7, 2.02]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.331

During the follow-up period (1.1.1998 — 31.12.2019), 2432 out of 11328 females with ASTHMA_MIXED_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_MIXED_EXMORE	1.806 [1.64, 1.98]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2457 out of 11523 males with ASTHMA_MIXED_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_MIXED_EXMORE.

N-year risk	Females	Males
1	0.163%	0.312%
5	1.025%	1.98%
10	2.663%	4.947%
15	5.052%	9.244%
20	9.006%	15.523%

Relationships between endpoints

↥

Index endpoint: ASTHMA_MIXED_EXMORE – Asthma mixed form (mode), excluding more controls

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Asthma mixed form (mode), excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints